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ABSTRACT 
Title: Functional tricuspid regurgitation: Mechanisms and determinants of severity 
Background: Functional tricuspid regurgitation (TR) important clinical condition associated 
with significant cardiac mortality and morbidity. Mechanisms and determinants of functional TR 
severity have not been well established. 
Study Aim: This prospective observational study was done with an aim to analyze the 
mechanisms of functional TR and to identify factors that independently determine its severity by 
transthoracic echocardiography in patients, aged 18 years and above, referred for 
echocardiography with various clinical indications. 
Material and methods: Between May 2010 and December 2010, a total of 110 functional TR 
patients and 21 controls underwent comprehensive echocardiographic assessment using 2 and 3-
dimensional echocardiography for determination of factors associated with TR severity, defined 
using standard criteria. Tricuspid annulus dimension, tricuspid valve (TV) tethering height, right 
heart geometry and function, left ventricular geometry and function, and systolic pulmonary 
artery pressure were assessed for significant association with TR severity. 
Results: Of the total 110 functional TR patients, forty seven patients had severe regurgitation. 
Thirty three had mild TR and thirty had moderate TR. Rheumatic valvular heart disease was by 
far the most common clinical condition present in these patients. Functional TR severity was 
associated with several measurements of right ventricular and tricuspid annulus geometry, right 
atrial size, right ventricular function and estimated pulmonary artery systolic pressure by 
univariate analysis. Tricuspid annulus contraction percent, indices of left ventricular function and 
geometry were not associated with regurgitation severity. TV tethering distance (p <0.001), end-
diastolic tricuspid annulus dimension (p=0.001), right ventricular end-systolic eccentricity index 
(RV-ESEI) (p=0.001) and end-systolic right atrial area (p=0.028) independently determined 
functional TR severity by multivariate analysis. The sensitivity and specificity for predicting 
more than moderate TR were 98% and 95% with a tricuspid annulus end diastolic diameter value 
of > 3.59 cm, and 96% and 91% with a tethering distance > 0.79 cm respectively. With 
increasing severity of functional TR, TV annulus enlarges and assumes a relatively circular 
shape with a greater increase in the antero-posterior annulus dimension. Degree of tethering was 
found to correlate with functional TR severity in all the three leaflets (p <0.001).  
Conclusion:  The role of TV annulus dilation and tethering of its leaflets in the pathogenesis of 
functional TR have been emphasized by this study. The study also provides valuable insights 
into the relationship between geometric alterations of the right sided cardiac chambers, tricuspid 
valve deformations and functional TR severity. Findings of this study have potential mechanistic 
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INTRODUCTION 
Tricuspid valve (TV) plays a pivotal role in the pathophysiology of left sided valvular 
disease and heart failure. Tricuspid regurgitation (TR) may be due to primary defects of the TV 
or more commonly, to secondary factors resulting in functional regurgitation despite a 
structurally normal valve. The development of TR, whether organic or functional, is associated 
with significant morbidity and mortality. 1-4  
Only a few studies have been done on the mechanisms of functional TR which is in 
contrast to the numerous studies done for elucidating mechanisms of functional mitral 
regurgitation (MR). Consequently, mechanisms and determinants of functional TR severity have 
not been well established. Hence this observational study was done with an aim to identify the 
various factors that independently determine functional TR severity. 
Management of functional TR has evolved from conservative approaches to a more direct 
approach such as TV annuloplasty. In 1967, a conservative approach to TR was proposed by 
Braunwald et al.5 Proper correction of the left-sided heart pathology was presumed to reduce or 
even abolish functional TR. Subsequently, it has become apparent that resolution of TR might 
not occur after mitral valve surgery and may even become evident several years later.  
In recent times, there has been an increased impetus to address functional TR, especially 
during surgery for left-sided heart pathology. Current approaches have provided unsatisfactory 
results.6-10 A better knowledge of the mechanisms that operate in the pathogenesis of functional 
TR could potentially lead to improved treatment measures, especially surgical. 
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 Data from prior studies suggest that annular dilatation of the TV and tethering of its 
leaflets mediates a key role in the generation of functional TR. At present, there is a paucity of 
data concerning the impact of morphological and functional changes of right side cardiac 
chambers and left ventricle, on the functioning and geometry of the TV. Since TV annulus is 
situated between right atrium and right ventricle, any pathology that affects either one of the 
chambers may have a significant effect on the functioning of the TV. Similarly TV is connected 
to the interventricular septum by the attachment of papillary muscles. Alterations of the left 
ventricular geometry and function may also impact on the function of TV because of ventricular 
interdependence or due to circulatory effects.   
 
STUDY PURPOSE AND HYPOTHESIS 
This prospective observational study was done to elucidate mechanisms and determinants 
of functional TR severity with the hypothesis that in addition to tricuspid annulus dilatation, 
other factors such as alterations of the geometry and function of the right side cardiac chambers 








AIM AND OBJECTIVES 
The present study, a prospective observational study, was undertaken with the following aim and 
objectives. 
Aim:  
The study aims to analyze mechanisms of functional TR and to identify factors that 
independently determine its severity by 2 and 3-dimensional transthoracic echocardiography in 
patients, aged 18 years and above, referred for echocardiography with various clinical 
indications. 
Objectives: 
1. To enumerate the etiological spectrum of functional TR diagnosed by echocardiography 
at a tertiary medical center.  
2. To identify factors associated with varying degrees of functional TR. 
3. To elucidate the anatomic, geometric and hemodynamic determinants of functional TR 
severity and to describe the potential mechanisms.  
4. To obtain data regarding tricuspid annulus dimension and deformations in patients with 
functional TR. 
5. To describe the distribution of TR severity in relation to pulmonary artery systolic 
pressure estimated by echocardiography and to identify factors associated with TR 
severity in patients with pulmonary artery hypertension. 
  4 
REVIEW OF LITERATURE 
FUNCTIONAL TR: ANATOMIC CONSIDERATIONS 
TV is the most apically positioned heart valve and has an intricate anatomic structure 
comprising of leaflet tissue (anterior, posterior and septal leaflets), supporting annular ring, 
chordae tendinae, papillary muscles, right atrium and right ventricular myocardium (figure 1).11 
Structural integrity and coordination of these components are needed for successful functioning 
of the TV.  
A. Valve leaflets. The three TV leaflets are of unequal size are attached to a fibrous annulus. 
The anterior leaflet is the largest and extends from the infundibular region to the 
inferolateral wall. The septal leaflet is the smallest and arises directly from the tricuspid 
annulus above the interventricular septum and extends to the posterior ventricular border. 
The posterior leaflet has multiple scallops and is attached along the posterior margin of the 
annulus from the septum to the inferolateral wall. 
B. Tricuspid annulus. The tricuspid annulus has a complex 3-dimensional structure, shape of 
which has implications for the design and application of currently available annuloplasty 
rings. The annulus has a non-planar elliptical structure, having two high points oriented 
rostrally towards the right atrium and two low points which are oriented inferiorly toward 
the right ventricle.12 Maintenance of TV competence is also maintained by the normal 
motion and contraction of the annulus. The tricuspid annulus dilatation occurs primarily in 
its anterior-posterior aspect, as the septal wall leaflet is fairly fixed and has little room for 
movement. The tricuspid annulus septal aspect may thus be considered to be analogous to 
the intertrigonal portion of the mitral annulus, which is also spared from annular dilation. 
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Thus dimensions of the base of the septal leaflet forms the basis of tricuspid annular sizing 
algorithms. 
C. Papillary muscles and Chordae. The chordal attachments to the anterior and posterior 
leaflets are provided by the anterior papillary muscle. The posterior and septal leaflets 
receive chordae from the medial papillary muscle. The anterior and septal leaflets receive 
chordae from the septal wall. Accessory chordal attachments to the moderator band and right 
ventricular free wall may additionally be present which can impair proper leaflet coaptation 




Figure 1. Tricuspid Valve Complex: The TV consists of anterior (A), posterior (P), and septal (S) 
leaflets, muscles, anterior (a) and posterior (p) and rudimentary septal (s) papillary muscles and chordae 
tendinae. AVN represents the atrioventricular node; CS, coronary sinus ostium; FO, foramen ovale. 
(Adapted with permission from Wolters Kluwer Health) 
 
 
Triangle of Koch Tendon of Todaro 
Inferior Vena Cava 




Right atrial appendage 
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HISTORICAL PERSPECTIVE 
Historically, concomitant repair of the TV during surgery for left heart valve lesion was 
less commonly performed because of the observation that functional TR often improves after 
such surgery. Braunwald et al5 analyzed hemodynamic data before and after procedure in 28 
patients with severe TR who had mitral valve replacement (of which only three underwent 
tricuspid annuloplasty). The authors concluded that mitral valve replacement alone leads to 
resolution of severe functional TR in most patients and therefore TV surgery was not indicated. 
This remained the dominant clinical view and practice for a long time. 
Carpentier et al13 advanced the opposing view of routine valve repair for functional TR 
and was almost universally ignored. Subsequently, with the widened application of cardiac 
surgery in the early 1970s, there became an increasing population of long term survivors of 
prosthetic mitral valve replacement. Several investigators then began to observe that many of 
these patients developed late heart failure as the result of severe TR. When such patients were re-
operated for repairing or replacing the TV, high mortality was observed. These observations lead 
many investigators to follow a liberal approach to annuloplasty at the initial mitral valve 






TRICUSPID REGURGITATION: ETIOLOGIES 
Etiology of TR can be physiologic or pathological (table 1). Pathological TR can be 
organic (primary TR) or functional (secondary TR).  Pathologic TR is more commonly 
functional, occurring secondary to left heart failure due to myocardial or valvular causes, right 
ventricular pressure overload, and enlargement of cardiac chambers. 
A. Physiologic TR.  Small degrees of TR are frequently encountered in normal 
individuals.14 These patients have normal valve morphology without any abnormality 
of the right ventricle on echocardiography. Physiologic TR is characterized by a thin 
central jet with peak systolic velocity of 1.7 to 2.3 m/s, confined to a small region 
adjoining the valve (<1 cm), and may not extend throughout systole.15 
B. Organic TR. Organic TR is related to direct involvement of TV by disease process 
and accounts for only 8-10% of severe TR.2 These primary disease processes include, 
infective endocarditis, carcinoid syndrome, congenital defects like Ebstein’s anomaly 
or Atrioventricular Canal defects, myxomatous degeneration with prolapse, trauma 
and iatrogenic damage (during heart surgery, biopsy and right heart catheter 
manipulation).15  
C. Functional TR. TR is said to be functional in a majority of patients. Functional TR is 
the result of adverse effects on RV function and geometry caused by left-sided heart 










Acute        Infective Endocarditis 
                  Traumatic (blunt chest injury, laceration) 
                  Iatrogenic (pacemaker/defibrillator leads, right ventricular biopsy) 
                  Anorectic drugs 
                  Papillary muscle dysfunction/ rupture 
Chronic    Rheumatic heart disease 
                  Myxomatous degeneration 
                  Carcinoid Syndrome 
                  Ebstein’s anomaly 
                  Endomyocardial fibrosis             
       Secondary (functional) 
               Left heart disease 
                        (Left ventricular dysfunction or valve disease resulting in pulmonary hypertension) 
               Any cause of pulmonary hypertension 
                        (chronic lung disease, pulmonary thromboembolism, left to right shunt, idiopathic etc) 
               Any cause of right ventricular dysfunction  
                              (myocardial disease, right ventricular ischemia or infarction) 
      Table 1. Etiology of Tricuspid regurgitation 
 
 
EPIDEMIOLOGY AND PROGNOSTIC IMPLICATIONS 
Incidence  
Mild physiologic TR is often observed in healthy individuals and has a prevalence of 65–
75%.14 Functional TR has a reported prevalence between 25% and 30% in patients undergoing 
left-sided valve surgery.16-18 Thirty percent of patients with cardiomyopathy have functional TR 
and its presence is considered a marker of poor prognosis.2,3,19  Nearly one-third of rheumatic 
mitral stenosis patients have more than mild functional TR.4 The incidence of significant TR in 
those undergoing surgery for functional MR was 14% in a study.20 Similarly, in valve prolapse 
related MR subjects, the incidence was 15% at the time of procedure.21 In a recent report, 
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McCarthy et al7 reported 32% prevalence of > 2+ TR on pre-operative echocardiography for  
patients having mitral valve procedures. Clinically severe TR occurs in 23% - 37% of patients 
after valve surgery for rheumatic mitral valve disease.22-24 Dreyfus et al25 reported 34% late 
significant TR in a small cohort of patients with varied etiologies for MR. Significant TR was 
observed in nearly 74% of patients three years after ischemic MR repair.9 
Impact of TR on survival and morbidity 
 In a large cohort study of 5507 patients who had echocardiography at the Veterans 
Affairs Health Care System, Nath et al2 found that TR of any etiology was associated with 
inferior survival. The survival for patients with severe regurgitation was 64% compared with 
90% in those with no regurgitation at one year.  Even after adjusting for age, ventricular 
function, moderate (hazard ratio, 1.17) and severe (hazard ratio, 1.31) TR remained predictive of 
long term mortality compared with those who had no TR. However this was a purely 
echocardiographic study of predominantly male Veterans Administration patients and the 
indications for the echocardiogram, presence of other valve dysfunction or cardiac pathology, 
and clinical history of the patients were not reported.  
 Lee et al26 in a more recent study observed a five year survival of 74% for patients with 
more than mild grade uncorrected isolated TR. Survival was worse in subjects with pulmonary 
hypertension or decreased right ventricular function in this study. 
Ruel et al27 reported moderate to severe TR to be an independent determinant of clinical 
events such as advanced cardiac failure, cardiac failure related mortality, and even all cause 
mortality during five year follow-up in a study. However, only 77% of the study subjects had 
echocardiographic follow up. Five year survival of 50% was reported after mitral valve surgery 
in rheumatic patients having severe TR, whereas mortality was nil in mild TR subjects.28   
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The quality of survival is also compromised by TR. Patients who develop TR after left 
heart valve replacement have a reduced exercise capacity.29 The presence of significant TR after 
mitral valve replacement was shown to predict New York Heart Association (NYHA) functional 
class III or IV at follow up.27 As compared with mild TR patients, those having moderate or 
severe TR prior to mitral valve replacement are more likely to have advanced congestive cardiac 
failure at late follow up (56% vs. 14%).30 
Poor outcome with increased perioperative deaths, poor late survival and functional status 
are observed in those who undergo isolated TV surgery for severe TR after mitral valve 
replacement.16,31-33 Perioperative mortality is usually between 11% and 20%, but can be as high 
as 50%.31,33-35 Mangoni et al31 reported operative mortality of 20% with a median survival of 1.2 
years in patients who had isolated TV replacement. Of the patients who survived in this study, 










MECHANISM OF FUNCTIONAL TRICUSPID REGURGITATION 
The pathogenesis of functional TR is considered to be complex and multifactorial. 
Pathologic process such as ischemia or rheumatic involvement of mitral valve leads to 
regurgitation or stenosis, resulting in elevated left atrial pressure and, if significant enough, can 
cause elevated pulmonary artery pressures. Right ventricular dysfunction and remodeling follows 
long standing pulmonary hypertension, and can result in tricuspid annulus dilatation and 
papillary muscle displacement with tethering of the leaflets. This in turn leads to significant TR 
(figure 2).8,36-39  
TR itself can cause further right ventricular dilatation and dysfunction with larger degree 
of annular dilation and leaflet tethering, and thus increasing the magnitude of regurgitation. The 
right ventricle significantly dilates and eventually fails with worsening TR. Right Ventricular 
diastolic pressure then rises and can shift the ventricular septum toward the left. Because of 
ventricular interdependence, septal shift results in restricted left ventricular filling and thereby 
elevating left ventricular diastolic and pulmonary artery pressures.35 
Left atrial enlargement or elevated left atrial pressure can predispose to atrial fibrillation. 
Atrial fibrillation can cause dilatation of right atrium resulting in further dilation of the tricuspid 
annulus. Atrial fibrillation is an important risk factor for the occurrence of TR in patients with 
left heart valve lesions. It is also associated with occurrence and persistence of TR after balloon 
mitral valvotomy or mitral valve surgery.40-42 Significantly less TR has been reported at follow 


















Figure  2.    Pathogenesis of Functional TR in Mitral Valve Disease 
DCMY stands for dilated cardiomyopathy; RV, right ventricle; AF, atrial fibrillation and LA, left 















Even though pulmonary hypertension is considered to be  important in the mechanism of 
late TR, it may not be elevated prior to mitral valve surgery.29 Pre-surgical pulmonary artery 
pressure did not predict late TR in a study by Porter et al.23 Kaul et al44  studied moderate 
functional TR subjects who had mitral valve replacement and reported lower incidence of late 
TR in severe pulmonary hypertension group when compared to those who hadn’t. They also had 
better functional capacity and survival. Non severe pulmonary hypertension group had worse 
right ventricular function in this study. Right ventricular function can predict outcomes in mitral 
valve disease patients with TR.33,45 The worse RV function in the non severe pulmonary 
hypertension group could have influenced the results. Another explanation is that these patients 
might have had organic TR rather than functional. 
One of the key factors in the genesis of late TR is tricuspid annulus dilatation and this is 
also the target for current surgical approaches. The tricuspid annulus becomes enlarged and the 
normal saddle shape becomes a more planar and circular structure with a decreased medio-lateral 
to anteroposterior ratio in functional TR.12,46 With increasing severity of functional TR, tricuspid 
area has been found to increase with reduction in the excursion of tricuspid annulus (29.6% in 
normal valves to 14.6% in patients with severe TR).46 
The tricuspid annulus flattening which occurs in significant TR subjects alters the normal 
papillary muscle to leaflet and annulus relationship leading to stretching of the low points of the 
annulus away from the papillary muscles (figure 3). This can result in increased tethering of the 














Figure 3. Tricuspid annulus. Left: control patient (normal tricuspid valve) with two high points 
located anteroposteriorly. Right: Functional TR patient where the annulus becomes flatter with 
no distinct high-point.  
 
Right ventricular geometry can be altered by various pathologies and can cause 
functional TR independent of TA dilatation. As mentioned earlier right ventricular dilatation 
results in papillary muscle displacement leading to increased tethering of the TV leaflets which 
in turn leads to TR. Strong correlation exists between tethering of leaflets and persistent TR after 


















FUNCTIONAL TRICUSPID REGURGITATION SEVERITY: INSIGHTS 
FROM PREVIOUS STUDIES 
 
Insight from 2-dimensional Echo studies 
In the early Nineties, Sagie et al39 investigated 109 patients with incomplete TV 
apposition using color flow Doppler and evaluated the factors associated with severity of TR. 
Sixty seven percent of the study subjects had severe TR. The only independent determinant of 
severity of TR in this study was dilation of the tricuspid annulus. A significant greater apical 
displacement of the tricuspid valve in subjects with severe TR was observed by the investigators 
at study completion (p <0.02). High pulmonary artery pressures and right ventricular 
enlargement did not correlate with severity of TR in this study. Authors also suggested that 
changes of the right ventricular shape rather than size to be important in the pathogenesis of TR. 
More than a decade later, Kim et al47 published a pioneering study substantiating the 
suggestion made by Sagie et al. Their study underscored the importance of alterations in right 
ventricular shape for predicting functional TR severity. The best correlation with the functional 
TR severity was shown by right ventricular end systolic eccentricity index, a novel 
echocardiographic measurement reflecting alterations in the right ventricular shape. Other 
parameters which independently predicted severity in this study was end diastolic tricuspid 
annulus dimension and tricuspid valve tethering area. As observed by Sagie et al, neither right 
ventricular enlargement nor pulmonary hypertension was found to be a pre- requisite for 
functional TR. 
Fukuda et al48 assessed relationship between functional TR severity and tricuspid valve 
deformations in a retrospective analysis of echocardiographic images of functional TR patients 
enrolled in the database of the Cleveland Clinic Foundation. Right atrial area, right ventricular 
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spherical index and tricuspid valve tethering height independently predicted functional TR 
severity in this study. TA dimension did not predict severity in this study. Right ventricular area 
and spherical index, left ventricular function and right atrial area were shown to influence 
tricuspid valve tethering height in this retrospective study.  
Seo et al49 evaluated the mechanisms of isolated TR in patients without significant 
pulmonary hypertension and found it to be associated with right ventricular remodeling, right 
ventricular systolic dysfunction, dilatation of the TA and tethering of the TV leaflets. 
Zhou et al50 found atrial fibrillation to be associated with significant annular dilation and 
regurgitation. Atrial fibrillation can cause significant right atrial dilatation which in turn can 
potentially cause dilatation of the annulus situated between the atrium and the ventricle. 
Insight from 3-dimensional Echo studies 
Ton-Nu et al12 studied the three dimensional geometry of the TV in patients with 
functional TR and noted two key findings. They described normal tricuspid annulus to be of 
saddle shape with high points situated in an anteroposterior orientation. Annulus was found to 
become more flatter and circular with a decreased mediolateral to anteroposterior ratio in 
patients with functional TR. As mentioned earlier, this results in increased tethering and 
regurgitation. 
 In another three dimensional echocardiographic study in patients with pulmonary 
hypertension, Sukmawan et al51 found enlargement of the tricuspid annulus tenting volume and 
diameter to be associated with functional TR. 
In yet another study by Fukuda et al,46 investigators noted an increase of tricuspid 
annulus area and diminution of tricuspid annular excursion with functional TR. The decrease in 
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excursion was most prominent in the severe TR group (14.6% versus 29.6% in healthy subjects, 
p = 0.001). 
Park et al52 determined the angles between the TV annulus plane and the three leaflets 
and found the angle between septal leaflet and tricuspid annulus plane, pulmonary artery systolic 
pressure and septal lateral diameter to be independent determinants of TR severity. 
What factors determine severity of residual functional TR after left sided heart surgery? 
Song et al53 observed the development of significant TR without prosthetic valve 
dysfunction, in subjects who had undergone uneventful left heart valve surgery. Factors 
associated with the progression of TR in their study were advanced age, female gender, rhythm, 
rheumatic etiology and pulmonary hypertension. 
What factors determine severity of residual functional TR after tricuspid annuloplasty? 
Tricuspid valve annuloplasty is now performed in many centers if the annulus is 
significantly dilated at the time of left heart surgery irrespective of the grade of TR. However, 
TR can persist and even progress in many of these patients. Such residual TR occurs in 10-20% 
of subjects early after tricuspid annuloplasty.54,55 
Fukuda et al8 investigated the factors associated with residual TR after tricuspid 
annuloplasty. In their study, TV tethering was observed to be the independent predictor of 
residual regurgitation early after annuloplasty. In a recent three dimensional echocardiographic 
study, Min et al56 evaluated the predictors of residual TR after annuloplasty. Pre annuloplasty 
tenting (tethering) volume and the tricuspid annulus dimension were observed to be the only 
independent predictors of severity. 
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CLINICAL ASSESSMENT OF TRICUSPID REGURGITATION 
Functional TR may present with symptoms related to underlying etiology or with features 
of right heart failure and low cardiac output state in advanced stages. Rarely severe TR can 
remain asymptomatic for several years. Prominent physical findings are related to the regurgitant 
murmur and right heart failure. In the advanced stages, patients may present with cachexia, 
cyanosis and jaundice.  
The classic triad of tricuspid regurgitation includes prominent ‘V’ in jugular venous 
pulse, pulsatile liver and systolic murmur exhibiting Carvallo’s sign.57 However the classic triad 
could be appreciated in only 42% of severe TR patients confirmed by right ventriculography in a 
study.58 See-saw movement of the precordium (hyperdynamic left parasternal systolic lift and 
retraction, accompanied by right parasternal lift), has been described in clinically significant 
TR.59,60 
Chest radiograph findings vary from normal sized right atrium to grossly enlarged right 
atrium depending on the degree of regurgitation. Electrocardiographic findings include atrial 
fibrillation and evidence of right sided chamber enlargement. Indirect and non specific evidence 
of TR include qR configuration in lead V1 and low amplitude QRS complex in lead V1 
compared to lead V2.61 Classic finding of TR during cardiac catheterization is the 
‘ventricularization’ of the right atrial pressure curve.57 Other findings include a large ‘V’ wave 
with a prominent y descent. This finding is accentuated during inspiration because of the 
physiologic increase in venous return. Main diagnostic tool for evaluation of TR is 
echocardiography. Cardiac Magnetic Resonance imaging is useful when echocardiographic 
evaluation is not conclusive for TR severity assessment and for assessing right ventricular size 
and function. 
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GRADING OF TRICUSPID REGURGITATION SEVERITY 
Assessment of functional TR severity and its grading is mainly done by 
echocardiography. Several echocardiographic parameters can be used to assess TR severity. 
These include quantitative parameters such as effective regurgitant orifice area, regurgitant 
volume, regurgitant fraction, vena contracta width and flow convergence width. Qualitative 
parameters include jet density and contour, pattern of hepatic vein flow and supportive 
parameters such as enlargement of right atrium and ventricle, and inferior vena cava. Grading of 
TR integrating various European and American guidelines and is summarized in table 2.62,63 
One of the main limitations for grading TR severity is the lack of a quantitative standard. 
Each of the mentioned methods has its own advantages and disadvantages and guidelines 
recommend integration of various parameters while grading regurgitation severity. Table 3 
summarizes the strengths and disadvantages of various parameters used in the grading of TR. 
Parameters Mild Moderate Severe 
Jet area (central jet), cm2 <5 5-10 >10 
Vena Contracta width, mm Not defined < 7 ≥ 7 
PISA radius, mm ≤5 6-9 ≥ 9 
Effective regurgitant orifice 
area, mm2 
Not defined Not defined ≥40 
Regurgitant Volume, ml Not defined Not defined ≥45 
Hepatic vein flow (systole) dominance blunting flow reversal 







Tricuspid inflow E wave velocity Normal Normal ≥1 cm/s 




Parameters Advantages  Limitations 
Vena Contracta 
width method 
*Relatively quick and easy 
* Relatively independent of 
hemodynamic and instrumentation 
factors 
 
*Not affected by other valve leak 
*Good for extremes TR: mild versus 
severe 
 
* Can be used in eccentric jet 
*Not valid for multiple jets 
*Small measurement errors leads to 
large % error 
 
*Intermediate values need confirmation 
*Affected by systolic changes in 
regurgitant flow 
PISA method * Can be used in eccentric jet 
* Not affected by the etiology of TR 
or other valve leak 
 
*  Quantitative: estimate lesion 
severity (Effective Regurgitant 
Orifice Area method) and volume 
overload (Residual Volume) 
 
* Large flow convergence at 28 cm/s 
alerts to significant TR 
* PISA shape affected 
– by the aliasing velocity 
– by systolic changes in regurgitant flow 
– by adjacent structures (flow 
constrainment) 
 
* Errors in PISA radius measurement 
are squared 
 
* Inter-observer variability 




* Systolic flow reversal specific for 
severe TR 
Affected by right atrial pressure, atrial 
fibrillation 
Color flow jet  * Ease of use 
* Evaluates the spatial orientation of 
TR jet 
 
* Good screening test for mild vs. 
severe TR 
* Can be inaccurate for estimation of 
TR severity 
 
 * Influenced by technical and 
hemodynamic factors 
 
*  Underestimates eccentric jet adhering 
the right atrial wall (Coanda effect) 
Table 3. Advantages and limitations of different parameters used for grading of severity of 
TR. PISA stands for proximal isovelocity surface area. 
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SURGICAL MANAGEMENT OF FUNCTIONAL TRICUSPID 
REGURGITATION 
Current practice patterns and guidelines for the management of TR and its evidence base 
The current practice recommendations by the American College of Cardiology (ACC) 
and American Heart Association (AHA)62, and European Society of Cardiology (ESC)63 are 
summarized in the table below (table 4). The agreement among the two guidelines is limited to 
the recommendation that severe TR should be treated in those who undergo left heart surgery 
(Class 1 recommendation). 
Guidelines for TV Repair for Functional TR according to the ACC/AHA and 
the ESC62,63 
ACC/AHA (2008) 
Class (I)    :  Severe TR in those who undergo mitral valve surgery (B) 
Class (IIb): “Less than severe TR” in those who undergo mitral valve surgery, with   
                     pulmonary artery hypertension or tricuspid annular dilatation (C) 
ESC (2007) 
Class (I)   :   Severe TR in those who undergo left-sided valve surgery (C) 
Class (IIa):   Moderate TR with annulus dimension >40 mm in those who undergo left heart      
                      valve surgery (C) 
Class (IIa):   Symptomatic severe TR late after left heart valve surgery without left  
                      sided myocardial, valve, or right ventricular dysfunction or severe pulmonary   
                      hypertension (C) 
Table 4. Indications for TV Repair in Functional TR 
 
Surgical management  
Goals of surgical management include correction of annulus dilatation, afterload reduction 
(reduction of pulmonary pressure by correction of left sided pathology) and tackling right 
ventricular dysfunction. Tricuspid annuloplasty done with an aim to restore tricuspid annulus 
geometry is the current standard procedure for functional TR. Two main approaches for 
annuloplasty are the suture and ring annuloplasty (figure 4).  
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Annuloplasty techniques 
Suture annuloplasty techniques are modifications of either bicuspidization (posterior 
plication technique) or De Vega annuloplasty. De Vega procedure involves plication of both the 
posterior and anterior annulus from the posterior extremity of the septal portion of the annulus 
upto the anteroseptal commisure. Durability of suture annuloplasty became an issue (tendency 
for suture dehiscence) for De Vega’s procedure and this was partially corrected by Antunes and 
Girdwood’s modification in which a Teflon pledget was used to buttress each suture. Because of 
high rates of recurrence and residual TR, suture annuloplasty techniques have been largely 
abandoned (table 5).   
 
 
Figure 4 . Surgical techniques for functional TR.  (A) Dilated tricuspid annulus. (B) Rigid 
annular bands restore normal size and shape. (C) De Vega annuloplasty (D) Suture (Adapted 
with permission from Wolters Kluwer Health) 
 
Ring annuloplasty is now considered by most surgeons as the procedure of choice among 
the various annuloplasty techniques for dilated tricuspid annulus. Advantages of ring and band 
annuloplasty include better distribution of the tension on the annuloplasty suture line, more 
standardized annular reduction and the ability to differentially plicate the annulus. Rings may be 
rigid, semi rigid or flexible, partial or complete.    
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 Bicuspidization Classic De Vega Flexible band Rigid ring 
Simplicity Simple Simple No No 
Annular 
stabilization 






Residual TR High Moderate Low Low 
Recurrent TR High Moderate Low Low 
Reproducibility Low Moderate High Very High 
Added time < 5min <10min 10-20 min 15-20 min 
Table 5. Comparison of various annuloplasty techniques 
Tricuspid Valve replacement versus repair 
Better midterm survival (up to 10 years post surgery) is observed with TV repair 
compared with replacement.  However there are no significant differences with regards to re-
operation or valve related mortality.64 Hypothesis for the difference in survival is that a rigid 
mechanical valve in a low pressure deformable chamber like the right ventricle can result in 
ventricular dysfunction and a low cardiac output state.  Potential thrombotic complications of 
mechanical and bioprosthetic valves can be avoided by choosing TV repair. 
Newer Advances and future perspective of TV surgery 
 Low 30- day mortality of 2.1% and a good repair rate (61%) were observed for minimally 
invasive TV surgery using mini thoracotomy.65  Successful implantation of percutaneous TV that 
consisted of a bovine jugular venous valve mounted to a nitinol frame has been described by 
Boudjemline et al66 in normal sheep. In future, Alfieri type edge to edge percutaneous repair may 
have a potential role for the management of functional TR. 
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RELEVANCE OF THE PRESENT STUDY 
 From the preceding discussion, it is clear that functional TR is an important clinical 
condition contributing to significant morbidity and mortality in patients with left sided heart 
pathology. Management of this condition is difficult and challenging as many patients present 
with advanced heart failure and diminished right ventricular function. As mentioned above, 
functional TR can appear late or even progress after correction of left sided pathology. 
Relationship between geometric changes of the right sided chambers, left ventricle, tricuspid 
valve deformations and severity of functional TR are unclear due to limited studies on this topic. 
Hence, a better knowledge of the mechanisms involved in the pathogenesis of functional TR 
could lead to improved treatment measures. This study, a prospective observational study, aims 
to address and clarify some of the earlier mentioned lacunae in the current understanding of the 
mechanisms of functional TR. This study is likely to give mechanistic insights into the 








STUDY DESIGN AND METHODOLOGY 
STUDY DESIGN 
The study was a single center prospective observational study done over a period of eight 
months. 
 The study was performed in accordance with the Declaration of Helsinki and its 
subsequent amendments, and within the framework of Good Clinical Practice. The study was 
approved by the hospital’s Research and Ethics Committee. The results of the study are reported 
adhering to the guidelines and addressing the checklist of the recent STROBE statement for 
observational studies (available at http://www.strobe-statement.org). 
 
SETTING 
The study was done in the Echocardiography lab of the Cardiology department of the Christian 
medical College Hospital, a 2500 bedded tertiary care hospital in South India. Echocardiography 




Patients aged 18 years and above, referred for echocardiography with various clinical indications 
and detected to have functional tricuspid regurgitation. 
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Exclusion criteria: 
The study excluded subjects who met the following criteria. 
1. Echocardiographic window which was suboptimal for a complete quantitative assessment 
of the tricuspid valve or the right ventricle. 
2. Prior TV repair or replacement. 
3. Acute right ventricular Dilation. 
4. Cardiac tamponade. 
5. Organic tricuspid valve disease. 
6. Permanent pacemaker implantation. 
7. Congenital heart disease and patients with evidence of right ventricular outflow tract 
obstruction. 
Study Controls: 
In addition, subjects who had sinus rhythm and no cardiac abnormalities were included for 
comparison of baseline parameters and to provide an estimate of normal values for various 






OUTCOME MEASURES AND VARIABLES 
Data Collection 
Standardized documentation sheets were used and data was collected exclusively by the 
primary investigator (Annexure I). Detailed clinical examination was done on all patients and 
relevant data was charted. Enrolled patients underwent comprehensive 2-dimensional, 3-
dimensional and Doppler echocardiographic evaluations.  
Echocardiographic evaluations and definitions 
Echocardiographic evaluation was done in a systematic manner using an 
echocardiography machine (Philips iE 33 Ultrasound machine, Philips Medical System). All 
examinations were recorded for off-line analysis. ECG gated images and loops were acquired in 
parasternal and apical views using a 1.0 -5.0 MHz sector array probe. The values of various 
echocardiographic parameters recorded were averaged over three cardiac cycles in sinus rhythm 
patients and five cardiac cycles in those who had atrial fibrillation. Three dimensional datasets 
were acquired during a breath-hold with ECG gating using 1.0-3.0 MHz Philips X3-1 
matrix Array transducer. Data sets were analyzed using dedicated software (4D Cardio-View™, 
image arena platform, Tomtec imaging systems, Munich, Germany and QLAB, Advanced 
Ultrasound Quantification Software, Philips) 
The following variables were measured by echocardiography. 
A. Right ventricular Geometry 
a. Right ventricular end-systolic and end-diastolic eccentricity index (figure 5). 
These indices were measured in the parasternal short axis view at the level of left 
ventricular papillary muscle.47 Eccentricity index was defined as the ratio of the 
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longest right ventricular distance (line ‘a’ in the figure 5) to the distance between 
ventricular septum and right ventricular free wall at the midpoint of the septum 
(line ‘b’ in the figure 5). This was measured at end-systole and end-diastole to 







Figure 5. Parasternal short axis view. Line ‘b’ (dotted line) measures distance between 
ventricular septum and right ventricular free wall at the midpoint of the septum. Line ‘a’ 
represents the longest the longest right ventricular distance. Eccentricity index was 
calculated as the ratio of ‘a’ to ‘b’. While calculating the length represented by line a, 
care was taken to exclude the infundibular area. 
 
b. Right ventricular spherical index. Right ventricular spherical index was 
calculated by dividing systolic right ventricular area by right ventricular long axis 
dimension.48 
c. Right ventricular long axis, mid cavity and basal dimension were measured 
from a right ventricle focused apical 4 chamber view at end diastole. Right 
ventricular mid cavity dimension: distance between right ventricular free wall 
and the septum measured in the middle third of the right ventricle at the level of 
left ventricular papillary muscles.  Long axis dimension: distance between tip of 







ventricular basal diameter was defined as the maximal short axis dimension in the 
basal third of the right ventricle (figure 6). 
d. Right ventricular end-diastolic & end - systolic area was calculated from the 
right ventricle focused apical 4 chamber view by planimetry tracing the 
endocardial outline of the right ventricle and the plane of the TV. 
  
Figure 6. Right atrial and ventricular dimensions. Line a represents right ventricular long axis 
dimension. Line b represents right ventricular mid cavity dimension. Line c represents right atrial 
major dimension. Line d represents right atrial minor dimension. RA stands for right atrium and 










B. Right Ventricular Function and Hemodynamic parameters 
a. Right ventricular fractional area change (FAC) was calculated as (end 
diastolic area - end systolic area)/ end diastolic area x 100. 
b. Tricuspid annular plane systolic excursion (TAPSE) was measured as the 
amount of longitudinal motion of the annulus at peak systole using an M-mode 
beam across the lateral annulus. 
c. Right Ventricular Tei index or myocardial performance index (RV MPI) was 
measured using color tissue Doppler. RV MPI= (tricuspid valve closure opening 
time- ejection time)/ ejection time. 
d. Myocardial acceleration during isovolumic contraction (IVA) was measured 
using color tissue Doppler. IVA = peak isovolumic myocardial velocity divided 
by time to peak velocity. 
e. Right ventricular systolic pressure (RVSP) / Systolic pulmonary artery 
pressure was estimated from the peak TR jet velocity (V) using Bernoulli 
equation and adding it to the estimated right atrial pressure.  RVSP = 4 (V)2 + 
estimated right atrial pressure. 
C. Tricuspid annulus and valve measurements  
a. End-systolic and end-diastolic TV annulus dimension was measured from the 
septal leaflet insertion point to the anterior leaflet point at end systole and end 
diastole respectively from an apical 4 chamber view. Tricuspid annular 
contraction was calculated as (End-diastolic TV annulus diameter - End-systolic 
TV annulus diameter) End-diastolic TV annulus diameter x 100. 
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b. Tethering height and area was measured from the apical four chamber view. 
Valve tethering area and height was measured by the area and distance 
enclosed between tricuspid leaflets and the tricuspid annular plane at the time 










Figure 7. Measurement of tricuspid valve tethering height and area. Shaded area represents 
tethering area. Arrow line measures the tethering height. RA stands for right atrium and RV 
stands for right ventricle. 
 
D. Right Atrial Parameters 
a. Estimation of right atrial pressure. Right atrial pressure was estimated 
integrating inferior vena cava (IVC) diameter and the presence of inspiratory 
collapse. Right atrial pressures were calculated as per the recommendations of 
American Society of Echocardiography (ASE) Guidelines 2010. 
Table 6 summarizes the values for Right atrial pressures based on IVC diameter 

















IVC diameter,cm ≤ 2.1 ≤ 2.1 > 2.1 >2.1 
Collapse with sniff >50% < 50% >50% < 50% 
                       Table 6. Estimation of right atrial (RA) pressure  
b. End-systolic Right atrial area was calculated by planimetry from the apical 4 
chamber view. 
c. Major dimension is calculated from apical 4 chamber window as the long axis 
distance of the right atrium from the center of the plane of TV annulus to the 
superior right atrial wall. 
d. Minor dimension is calculated as the distance between the mid-point of right 
atrial free wall to the inter-atrial septum perpendicular to the long axis. 
E. Left Ventricular parameters 
a. Left Ventricular ejection fraction was calculated using Simpson’s method from 
the apical views. 
b. Left ventricular long axis dimension was obtained from the apical 4 chamber 
window as the distance between tip of ventricular apex and the midpoint of the 
mitral valve annular plane. 
c. Left Ventricular spherical index was obtained by dividing left ventricular end-
systolic volume by the left ventricular long axis dimension in the apical 4 
chamber window. 
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F. Pulmonary artery hypertension - defined as estimated systolic pulmonary artery 
pressure (RVSP) more than 50 mmHg, estimated by the method mentioned above 
(see section on ‘Right Ventricular Function and Hemodynamic parameters’). 
G. Grading of severity of functional TR 
a. Functional TR was defined as the presence of TR in the absence of organic TV 
disease or prior TV surgery. 
b. Grading of tricuspid regurgitation.  Functional TR was graded based on the 
criteria used in the Framingham heart study and by incorporating qualitative and 
quantitative parameters for severe TR as recommended by various guidelines.63,67 
According to the criteria used by Singh et al67, TR was classified as mild if jet 
area/ Right atrial area < 19%, moderate if between 20-40% and severe if >40%. 
Same criteria was used in another study on TR by Nath et al.2 Values of 
quantitative parameters for grading TR as severe were vena contracta width >7 
mm and effective regurgitant orifice area, EROA >40 mm2. EROA was measured 
using the proximal isovelocity surface area method and was calculated as EROA= 
2x Π x [radius of the proximal isovelocity surface (in centimeter)]2 x aliasing 
velocity (in centimeter per second) / Peak velocity of the functional TR (in 
centimeter per second). Vena contracta width was measured at midsystole as the 
narrowest neck of regurgitation, just distal to flow convergence region. 
H. Three dimensional echocardiography measurements 
a. Tricuspid annulus dimension. TV annulus shape and dimensions were 
assessed on a short axis image plane. Septal-lateral and antero-posterior 
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longitudinal planes were obtained using method described by Park et al52 to 
measure the septal-lateral and antero-posterior annulus diameter 
b. Angles between TV leaflets and the annulus plane. Three longitudinal 
planes that perpendicularly crossed the middle of each TV leaflet were 
obtained and on each of these planes, angles between the annulus plane and 
the leaflets were measured on a mid systolic frame. They were named as 
septal, anterior and posterior angle (figure 8a,b,c). 
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Commercially available statistical software (‘IBM SPSS Statistics software version 18’, 
Illinois, Chicago) was used for data analysis. All continuous variables were expressed as mean ± 
SD and categorical variables were expressed as number (percentage). Comparative analysis of 
the three study groups (mild, moderate & severe TR) was performed by one way analysis of 
variance (ANOVA) with appropriate post hoc tests (Scheffe and Games Howell) for continuous 
variables with a normal distribution. In brief, Scheffe test was used when assumption of 
homogeneity of variances was met and Games Howell test used when it was not met. Kruskal-
Wallis one way analysis of variance by ranks was used for comparative analysis of continuous 
variables with a skewed distribution. Independent samples T test was used for comparative 
analysis of two groups with a normally distributed continuous variables. Mann Whitney U test 
was used for comparison of continuous variables which were not normally distributed. 
Comparison of categorical variables was done by Chi square test. Pearson correlation coefficient 
was used to analyze the correlation between continuous variables with a normal distribution. The 
echocardiographic parameters which were independently associated with functional TR severity 
were identified by multiple stepwise linear regression analysis. P value less than 0.05 by 
univariate analysis was used as the entry cut off for the multivariate analysis. The sensitivity and 
specificity of various cut-off points that reliably predicted functional TR of more than moderate 
degree was calculated by plotting receiver-operator characteristic curves. Lin’s concordance 
correlation coefficient (ρ-c) was calculated to assess intra-observer and inter-observer variability. 




Methodology: Statement of Limitations and Ethical Issues 
Statement of Limitations 
1. Referral bias. The hospital being a tertiary medical center, possibility of referral bias was 
considered. Since TR prevalence was not the main outcome of the study, any referral bias was 
not expected to affect the study analysis. 
2. Physiologic conditions, settings of the machine and characteristics of the jet can influence 
methods used to quantify TR severity. 
3. At present, there is a lack of standardized measurements and specific software for quantitative 
assessment of tricuspid annulus and leaflets by 3-dimensional echocardiography. 
Ethical Issues 
As mentioned earlier, the study was conducted in accordance with the Declaration of Helsinki 
and within the framework of Good Clinical Practice. The study protocol was presented before 
the Research and Ethics Committee of this institution. Various ethical issues pertaining to the 
study were discussed. The study was cleared by the Committee. Informed consent document is 
attached under annexure. 
Key ethical issues 
Some of the key ethical issues related to the study are listed below. 
1. By participating in this study, there were no added risks involved to the participants. 
2. Selection of subjects was fair and there was no discrimination with regard to age, sex, social 
status, caste or religion while choosing subjects. 
3. Steps were taken to maintain confidentiality of the data collected. 
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4. Scientific validity: Well accepted scientific principles and methods were used to produce 
reliable data. 
5. Copyright permissions were obtained from the author and publisher while reproducing select 

















I.  STUDY PROFILE & BASELINE CHARACTERISTICS 
Between May 2010 and December 2010, a total of 174 patients with functional TR were 
screened for inclusion into the study. Forty six patients were excluded because of 
echocardiographic window which was suboptimal for a complete quantitative evaluation of the 
tricuspid valve or the right ventricle. Six patients were excluded because of organic tricuspid 
valve disease. Three patients had past history of tricuspid annuloplasty and were excluded. Three 
patients were excluded because of permanent pacemaker implantation. Six patients were 
excluded because of Ebstein’s anomaly of the TV.  After exclusions, a total of 110 functional TR 
patients were included in the study. Figure 10 shows the flow and profile of patients in this 
study. 
Of the total 110 functional TR patients, 33 (30%) had mild TR, 30 (27%) had moderate 
TR and 47 (42%) had severe TR.  Twenty one patients formed controls which were used for 
comparison of baseline parameters and to obtain an estimate of the normal values for various 
echocardiographic parameters such as tricuspid annulus dimension, tethering area, tethering 
distance, and right ventricular spherical and eccentricity index. Table 7 shows the various 
echocardiographic and clinical parameters of the entire study population. Mean age of the 
functional TR patients was 42 ± 15 years. Fifty nine percent of them were females. The mean 
body surface area was 1.45 ± 0.17 sq cm. Forty percent of the functional TR group had atrial 
fibrillation. Mean heart rate was 88 ± 19 beats per minute and was comparable to that of the 














































































































Age, years 42 ± 15 48 ± 13 0.053 
Females, n (%) 65 (59) 9 (43) 0.169 
Height, cm 156 ± 9 159 ± 10 0.302 
Weight, kg 49 ± 10 57 ± 9 0.001 
BSA, m2  1.45 ± 0.17 1.57 ± 0.16 0.003 
Rhythm                       Sinus, n 







NYHA Class (n)               I 
                                          II 





Heart rate (beats per minute) 88 ± 19 83 ± 9 0.215 
Left ventricle 
• End diastolic volume, ml 
• End systolic volume, ml 
• Ejection fraction,% 
• Spherical index 
 
100.9 ± 52.8 
47 ± 33 
55 ± 9 
6.85 ± 4.4 
 
87.7 ± 15.6 
36.4 ± 6.6 
59 ± 2 







• Mid dimension, cm 
• Basal dimension, cm 
• Long axis dimension, cm 
• Eccentricity index: End systolic 
                            : End diastolic  
• Spherical index 
• Fractional area change,% 
• Tei index(MPI)
 
3.4 ± 0.8 
4.5 ± 0.9 
6.6 ± 0.9 
2.11 ± 0.22 
2.14 ± 0.25 
2.05 ± 0.75 
38.3 ± 7.7 
0.59 ± 0.14 
 
2.3 ± 0.2 
3.1 ± 0.3 
6.1 ± 0.4 
1.91 ± 0.13 
1.89 ± 0.12 
1.35 ± 0.22 
41.2 ± 6.9 











• Major dimension, cm 
• Minor dimension, cm 
• End systolic area, cm2 
 
5.5 ± 1.2 
4.3 ± 1.1 
21.91 ± 8.56 
 
3.6 ± 0.3 
3.2 ± 0.4 






• End diastolic diameter, cm 
• Indexed End diastolic diameter, cm/m2 
• End systolic diameter, cm 
• Indexed End systolic diameter, cm/m2 
• Annulus contraction % 
 
3.53± 0.67 
2.46 ± 0.52 
3.01 ± 0.62 
2.09 ± 0.47 
15 ± 4 
 
2.59 ± 0.19 
1.65 ± 0.19 
2.25 ± 0.17 
1.44 ± 0.16 







Tricuspid valve tethering height, cm 0.81 ± 0.37 0.18 ± 0.04 < 0.001 
Isovolumic acceleration, m/s2 3.14 ± 1.18 4.46 ± 1.42 < 0.001 
Tricuspid annular plane systolic excursion, 
cm  
1.93 ± 0.39 2.25 ± 0.17 < 0.001 
         Table 7. Echocardiographic and clinical characteristics of the entire study population. 
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Patients and controls were comparable for various indices of left ventricular function and 
geometry. There were no significant differences between the two groups for age, sex, height, 
heart rate or the right ventricular FAC. The functional TR patients had significantly lower weight 
and body surface area compared to normal subjects. Significant differences between the 
functional TR and normal subjects were observed for various indices of right ventricular function 
and geometry, tricuspid annulus and right atrial measurements. Mean tricuspid annulus 
dimension (end diastolic) was 3.52 ± 0.67 cm in the functional TR group and 2.59 ± 0.19 cm in 
normal subjects group. We also recorded TAPSE, right ventricular myocardial performance 
index and isovolumic acceleration, values of which were significantly different between the 
groups.  
Based on the criteria mentioned earlier under methodology, functional TR patients were 
classified into three groups- mild, moderate and severe. Mean values with standard deviations of 
various quantitative parameters of tricuspid regurgitation severity are presented in table 8.  The 
mean values of vena contracta and effective regurgitant orifice area of patients belonging to 
severe functional TR group were 8.1 mm and 46.1 mm2 respectively. 
  Table.8 Echocardiographic parameters of tricuspid regurgitation severity 






Vena Contracta (mm) 2.6 ± 0.6 5.6 ± 0.8 8.1 ± 1.8 
Effective Regurgitant 
Orifice area (mm2) 
7.3 ± 3.6 15.8 ± 6.2 46.1 ± 7.5 
Trans tricuspid E wave 
velocity (cm/sec) 
67.8 ± 15.2 77.8 ± 15 104.6 ± 22 
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Clinical Characteristics of the patients belonging to the three groups of severity of functional TR 
are presented in table 9. 
  Table 9. Clinical Characteristics of the study population. Values are expressed as number 
(percentage). ACE, angiotensin converting enzyme. 
 
II. ETIOLOGY OF FUNCTIONAL TR 
Spectrum of clinical diagnosis in patients with functional TR in this study is summarized 
in the table given below (see table 10). Rheumatic valvular heart disease especially involving 
mitral valve was by far the most common clinical condition present in patients with functional 
TR. Seventy percent of cases had rheumatic valvular heart disease. Other causes for functional 
TR in this study included dilated cardiomyopathy, ischemic cardiomyopathy, primary pulmonary 
hypertension, Cor pulmonale, chronic liver disease and non rheumatic left side valvular heart 
disease (figure 11).  







Atrial Fibrillation 5 (15) 13 (43) 26 (55) 0.001 
Systolic Murmur 4 (9) 5 (17) 37 (79) < 0.001 
‘V’ waves JVP 0 (0) 4 (13) 36 (77) < 0.001 
Ascites 0 (0) 1 (3) 5 (10) 0.121 
Pedal Oedema 0 (0) 1 (3) 5 (10) 0.121 
Pulsatile liver 0 (0) 1 (3) 17 (36) < 0.001 





















Diuretics 26  (79) 25 (83) 43 (91) 0.247 
Digoxin 16 (48) 20 (67) 37 (79) 0.019 
Betablockers 14 (42) 11 (37) 13 (28) 0.377 
ACE inhibitors 7 (21) 6 (20) 9 (19) 0.975 
Angiotensin II receptor blocker 2 (6) 1 (3) 1 (2) 0.815 
Calcium channel blockers 5 (15) 10 (33) 15 (32) 0.173 
  
































































































III. MECHANISMS AND DETERMINANTS OF FUNCTIONAL TR SEVERITY 
A.  Comparison  of  clinical  and  echocardiographic  parameters  between  the 
three groups of functional TR 
 
 The clinical and echocardiographic measurements of the three study groups of functional 
TR are presented in Table 11. Comparative analyses across the three groups were done by 
ANOVA with post hoc tests for continuous variables and chi-square tests for categorical 
variables. There were no significant differences between the groups with regard to age, gender, 
left ventricular volumes, left ventricular ejection fraction, left ventricular spherical index and 
tricuspid annulus contraction.  
Severe functional TR group had significantly more number of subjects with atrial 
fibrillation. There was a statistically significant trend for right ventricular end-systolic and end-
diastolic eccentricity index, tricuspid annulus dimension (end-diastolic and end-systolic), 
tricuspid valve tethering height and area, and end systolic right atrial area to increase as 
functional TR increased from mild to severe (p value for linear trend < 0.001) (figure 12). Severe 
functional TR group had significantly greater right ventricular dimensions when compared with 
the other two groups (p <0.001). Estimated Pulmonary artery systolic pressure was also 
significantly higher in the severe group as compared to the other groups. This could be due to the 
predominant rheumatic etiology. Moderate and severe groups had significantly lower right 














Age, years 39 ± 17 41 ± 14 43 ± 13 0.403 - 
Men, n (%) 14 11 20 0.858 - 
Atrial Fibrillation, n (%) 5 13 26 0.001 - 
Left Ventricle 
• End diastolic volume, ml 
• End Systolic volume, ml 
• Ejection Fraction, % 
 
87.7 (71.7 -107.8) 
36 (29.8 -  47.4) 
55.7 ± 8.9 
 
97.7 (81.8 - 122.5) 
41.4 (33 - 72.3 ) 
55.2 ± 9 
 
83.1(62.7 - 111) 
32.6 (25.8 - 54.1) 






Left Ventricular spherical index 6.58 ± 4.09 7.79 ± 4.81  6.43 ± 4.38 0.390 - 
Right Ventricle 
• Basal dimension, cm 
• Mid dimension, cm 
• Longitudinal dimension, cm 
 
3.9 ± 0.6 
2.8 ± 0.5 
6.2 ± 0.7 
 
4.08 ± 0.6 
3.1 ± 0.7 
6.4 ± 0.8 
 
5.2 ± 0.8* 
3.9 ± 0.7* 







Right Ventricular spherical index 1.58 ± 0.33 1.80 ± 0.41 2.53 ± 0.85* < 0.001 - 
Right Ventricle 
• End systolic EI# 
• End diastolic EI# 
 
1.90 ± 0.15 
1.97 ± 0.15 
 
2.08 ± 0.10 § 
2.11 ± 0.18 § 
 
2.28 ± 0.20* 





Estimated Pulmonary artery 
systolic pressure, mmHg 
43 ± 15 53 ± 19 70 ± 27 § < 0.001 - 
Tricuspid Valve 
• Tethering area, cm2 
• Tethering Height, cm 
 
0.74 ± 0.27 
0.45 ± 0.14 
 
1.16 ± 0.43 § 
0.69 ± 0.18 § 
 
2.30 ± 0.70* 





Tricuspid Annulus  
• End systolic dimension, cm 
Indexed end systolic dimension, cm/m2 
• End diastolic dimension cm 
Indexed end diastolic dimension, cm/m2 
• Annulus Contraction, % 
 
2.41 ± 0.29 
1.70 ± 0.27 
2.85 ± 0.31 
2.01 ±0.31 
15 ± 5 
 
2.79 ± 0.26 § 
1.93 ± 0.22 
3.27± 0.28 § 
2.26 ± 0.26 
15 ± 4 
 
3.57 ± 0.44* 
2.48 ± 0.39* 
4.17 ± 0.39* 
2.90± 0.39* 
15 ± 4 
 
<0.001 
"   
<0.001 








Right Atrial End systolic area, cm2 15.01 ± 3.26 19.35± 3.06 § 28.38 ± 8.88* < 0.001 < 0.001
Right Ventricular Fractional area 
change, % 
42.3 ± 5.7 38.2 ± 6.4 § 35 .6 ± 8.5 § < 0.001       - 
TAPSE 2.16 ± 0.28 1.96 ± 0.31 1.73 ± 0.41§ < 0.001 - 
Right Ventricular MPI 0.54 ± 0.09 0.59 ± 0.14 0.62 ± 0.15 0.023 - 
Isovolumic acceleration 3.4 ± 1.2 3.6 ± 1.0 2.6 ± 1.1 < 0.001 - 
Table 11. Comparison of various clinical and echocardiographic parameters of three groups of 
functional TR.  
*p < 0.001 versus mild & moderate group 
§p < 0.001 versus mild group                                          p <0.05 versus moderate group 
p < 0.05   versus mild group                                          p <0.005 versus moderate group 
#EI- Eccentricity index. 
Analysis was done using ANOVA except for left ventricular volumes where Kruskal Wallis test used. 

















          
 Figure 12. Comparison of tricuspid valve tethering height (A), end diastolic tricuspid 
annulus diameter (B), Right atrial end-systolic area (C) and right ventricular end - systolic 






0.45 ± 0.14  0.69 ± 0.18  1.14 ± 0.26
C  D 
p < 0.001 








2.85 ± 0.31 3.27± 0.28  4.17 ± 0.39
15.01 ± 3.26  19.35± 3.06  28.38 ± 8.88 1.90 ± 0.15 2.08 ± 0.10  2.28 ± 0.20
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B. Independent determinants of functional TR severity 
After considering plausibility, select echocardiographic parameters were tested for 
significant correlation with effective regurgitant orifice area treated as a continuous variable. 
Several measurements of right ventricular and tricuspid annulus geometry, right atrial size, right 
ventricular function and estimated pulmonary artery systolic pressure were observed to show 
significant correlations with the effective regurgitant orifice area by univariate analysis (table 
12). Tricuspid annulus contraction percent and other indices of left ventricular function or 
geometry did not correlate significantly with the effective regurgitant orifice area. 
Among the variables shown to have significant correlation with the regurgitant orifice 
area, tricuspid annulus dimension (end-diastolic and end-systolic), tricuspid valve tethering 
height and area showed the strongest correlation (r = 0.864, 0.834, 0.816 and 0.806 respectively, 
p <0.001).  Scatter plots shown in figure 13 show the relationship between effective regurgitant 
orifice area and some of these parameters.  
Using the aforementioned significant variables by univariate analysis, a multivariate 
stepwise linear regression analysis was done to identify independent determinants of functional 
TR severity.  TV tethering distance, end-diastolic tricuspid annulus dimension, end-systolic 
eccentricity index and end-systolic right atrial area were found to independently determine 
effective regurgitant orifice area and thus severity. Same variables were also found to 
independently determine severity when relative size of the tricuspid regurgitation jet to the right 







              
    
 
Figure 13. Scatter plot showing correlations of effective regurgitant orifice area with tricuspid 
valve tethering height (A), right ventricular end systolic EI (B) and end-diastolic tricuspid 





 p < 0.001 
 p < 0.001
 p = 0.002 
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Right Ventricular Basal Dimension 0.665 < 0.001 0.630 - 
Right Ventricular Mid Dimension 0.582 < 0.001 0.968 - 
Right Ventricular longitudinal 
Dimension 
0.415 < 0.001 0.902 - 
Right Ventricular end-diastolic area 0.605 < 0.001 0.878 - 
Right Ventricular end-systolic area 0.556 < 0.001 0.823 - 
Right Ventricular FAC 0.280 0.003 0.609 - 
Right Ventricular Tei index 0.197 0.039 0.301 - 
Tricuspid valve tethering area 0.806 < 0.001 0.874 - 
Tricuspid valve tethering height 0.816 < 0.001     < 0.001 0.406 
Tricuspid annulus dimension, end 
systolic 
0.834 < 0.001 0.967 - 
Tricuspid annulus dimension, end 
diastolic 
0.864 < 0.001        0.001 0.313 
Right atrial end-systolic area 0.700 < 0.001  0.028 0.135 
Pulmonary Artery systolic pressure 0.363 < 0.001  0.686 - 
Right Ventricular Spherical index 0.536 < 0.001 0.746 - 
Right Ventricular End systolic EI# 0.695 0.002 0.001 0.197 
Right Ventricular End diastolic EI# 0.519 < 0.001 0.894 - 
Table 12. Univariate and multivariate analysis. Relationship of various echocardiographic 
measurements with effective regurgitant orifice area. (Adjusted R2 for the model- 0.827)  




C. Receiver‐operator  characteristic  (ROC)  curves  for  parameters  predicting 
severity 
ROC curves were used to examine the sensitivities and specificities of various cut off 
points of parameters that predicted more than moderate functional TR (figure 14). Table 13 
summarizes the cut off values, their sensitivities, specificities and calculated positive likelihood 
ratio. Tricuspid annulus end diastolic diameter value of more than 3.59 cm had a sensitivity and 
specificity of 98% and 95% respectively in predicting more than moderate functional TR. 
 
Variable Cut Off 
Value 
Sensitivity Specificity Positive 
likelihood ratio
 











End diastolic tricuspid 























































Table 13. Cut off values of predictor variables with their sensitivities and specificities.  
#EI- Eccentricity index. 
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 Figure14. Receiver-operator characteristic (ROC) curves of tethering height, tricuspid annulus 
dimension, right ventricular end systolic EI and end systolic right atrial end systolic area 
 
Variable Area Under 
ROC Curve 
p 95 % CI 
Tethering height 0.969  < 0.001 0.94 - 0.99 
End diastolic tricuspid annulus 
diameter 
0.996 < 0.001 0.00 – 1.00 
Indexed Tricuspid annulus end-
diastolic dimension 
0.956 < 0.001 0.92 - 0.99 
Right Ventricular end systolic EI# 0.921 < 0.001 0.87 - 0.97 
Right atrial end-systolic area 0.914 < 0.001 0.86 - 0.97 




 Significant correlation was found between end diastolic tricuspid annulus and tethering distance 
as shown in figure 15. 
                      
Figure 15. Scatter plot showing correlation of tricuspid valve tethering height with the end 
diastolic tricuspid annulus dimension. 
 
Factors that determined tricuspid valve tethering distance and end diastolic tricuspid 
annulus dimension independent of each other were examined. Tethering distance correlated with 
several right sided chambers indices and estimated pulmonary artery systolic pressure. When all 
the significant variables by univariate analysis were included in a stepwise linear regression 
model, right ventricular end-diastolic area (p < 0.001), right atrial end-systolic area (p= 0.040) 
and right ventricular end systolic eccentricity index (p =0.002) determined tethering height (table 
15a). 
 Similarly, several indices of right ventricular geometry and function correlated with end-
diastolic tricuspid annulus dimension.  Right ventricular basal dimension (p < 0.001), right atrial 
y = 1.3806 x + 2.4061 
R² = 0.5683  
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end-systolic area (p < 0.001),  and right ventricular end systolic eccentricity index (p < 0.001),  
were identified as independent factors that correlated with end- diastolic tricuspid annulus 
dimension when analyzed by stepwise linear multivariate regression (table 15b). 
Variable r Univariate p Multivariate p 
Right Ventricular Basal dimension 0.680 < 0.001 0.250 
Right Ventricular long- axis dimension 0.492 < 0.001 0.504 
Right Ventricular FAC 0.341 < 0.001 0.800 
Right Ventricular end-diastolic area 0.685 < 0.001           < 0.001 
Right Ventricular end-systolic area 0.642 < 0.001 0.079 
Right Ventricular Mid dimension 0.657 < 0.001 0.308 
Right atrial end-systolic area 0.567        < 0.001 0.040 
Estimated Pulmonary artery systolic 
pressure 
0.424        < 0.001  0.771 
Right Ventricular Spherical index 0.612 < 0.001 0.206 
Right Ventricular End systolic EI# 0.494 < 0.001 0.002 
Right Ventricular  End diastolic EI# 0.342 < 0.001 0.321 
Table 15a. Determinants of tricuspid valve tethering height. #EI- Eccentricity index. 
 
Variable r Univariate p Multivariate p 
Right Ventricular Basal dimension 0.688 < 0.001           < 0.001 
Right Ventricular long- axis dimension 0.420 < 0.001 0.126 
Right Ventricular FAC 0.218   0.022 0.897 
Right Ventricular end-diastolic area 0.601 < 0.001 0.295 
Right Ventricular end-systolic area 0.536 < 0.001 0.406 
Right Ventricular Mid dimension 0.568 < 0.001 0.343 
Right atrial end-systolic area 0.750        < 0.001           < 0.001 
Estimated Pulmonary artery systolic 
pressure 
0.285           0.003  0.837 
Right Ventricular Spherical index 0.511 < 0.001 0.491 
Right Ventricular End systolic EI# 0.730 < 0.001           < 0.001 
Right Ventricular  End diastolic EI# 0.550 < 0.001 0.321 
Table 15b. Determinants of end-diastolic tricuspid annulus dimension. #EI- Eccentricity index.  
Results of the 3-Dimensional echocardiographic assessment of the tricuspid valve 
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Quantitative analysis of the 3D data revealed that functional TR group had a significantly 
larger tricuspid annulus area, circumference, septal-lateral and anteroposterior dimension (table 
16a). Severe functional TR group had a larger annulus area and a longer circumference when 
compared with the other two groups (table 16b). Severe functional TR group also had 
significantly greater septal-lateral and antero-posterior tricuspid annulus dimension. With 
increasing severity of TR, annulus was found to assume a circular shape with greater increase in 
the antero-posterior annulus dimension. Degree of tethering was found to correlate with 
functional TR severity in all three leaflets (figure 16). Angle between septal leaflet and tricuspid 
annulus plane correlated best with tethering height and effective regurgitant orifice area (table 17). 
   Table 16a. Comparison of 3-D echocardiographic parameters 
  Table 16b. Comparison of 3-D echocardiographic parameters between the three groups of TR 
  *Ratio of longest/ shortest annulus diameter 
Variable Control Functional TR p 
Tricuspid annulus area,  cm2 7.2 ± 0.9 10.3 ± 3.6 < 0.001
Tricuspid annulus Perimeter cm 9.1 ± 2.1 11.1 ± 2.1 < 0.001
Septal-lateral diameter, cm 2.95 ± 0.22  3.57 ± 0.58 < 0.001








Septal angle 19.8 ± 6.2o 26.0 ± 5.6 o 39.5 ± 6.1 o < 0.001
Anterior Angle 14.7 ± 5.2o 20.6 ± 5.6 o 31.9 ± 6.0 o < 0.001
Posterior Angle 16.6 ± 4.8o 22.7 ± 5.7 o 33.9 ± 5.2 o < 0.001
Tricuspid annulus area,  cm2 7.1 ± 1.2 8.6 ± 1.2 13.7 ± 2.7 < 0.001
Tricuspid annulus Perimeter cm 9.4 ± 0.8 10.4 ± 0.7 13.4 ± 1.3 < 0.001
Septal-lateral diameter, cm 3.12 ± 0.24  3.19 ± 0.23 4.13± 0.40 < 0.001
Anteroposterior diameter, cm 2.82 ± 0.24  3.43 ± 0.24 4.27 ± 0.39 < 0.001




                                       
Figure 16. Scatter plots showing relationship of angle between tricuspid annulus plane and the 
anterior, septal, posterior leaflets with effective regurgitant orifice area 
Table17.  Correlations of angle between tricuspid annulus plane and the anterior, septal, posterior 
leaflets with effective regurgitant orifice area and TV tethering height                                 
 
Correlation with TV 
tethering height 
Correlation coefficient, r 
p 
(2 tailed) 
Correlation with Effective 
regurgitant orifice area 
Correlation coefficient, r 
p 
(2 tailed) 
Septal angle 0.796 0.01 0.781 0.01 
Posterior Angle 0.760 0.01 0.765 0.01 
Anterior Angle 0.760 0.01 0.766 0.01 
y = 0.3862x + 13.528 
R² = 0.5873  
y = 0.4396x + 18.37 
R² = 0.6105  
y = 0.3736x + 15.877 



































































































































In patients with PASP > 50, tricuspid annulus dimension, tethering height and area, right 
ventricular basal dimension and right ventricular end systolic eccentricity index showed good 
correlation with effective regurgitant orifice area (table 18). Peak TR gradient was not associated 
with the severity of TR.  End diastolic tricuspid annulus dimension (p =0.004) and tethering 
height (p= 0.009) were the independent determinants of functional TR severity by multivariate 




Right Ventricular Basal dimension 0.602         < 0.001 
Right Ventricular Mid dimension 0.436 0.001 
Right Ventricular long- axis dimension 0.378 0.004 
Right Ventricular FAC - 0.272 0.041 
Right Ventricular Tei index 0.239 0.073 
Tricuspid annulus dimension, end diastolic 0.814         < 0.001 
Tricuspid annulus dimension, end systolic 0.737         < 0.001 
Tethering area 0.683         < 0.001 
Tethering Height 0.736         < 0.001 
Right atrial End-systolic area 0.445 0.001 
Peak TR Gradient 0.181 0.178 
Right Ventricular Spherical index 0.429 0.001 
Right Ventricular End systolic EI# 0.525         < 0.001 
Right Ventricular End diastolic EI#           0.395 0.002 
Left Ventricular ejection fraction         - 0.200 0.136 
Left Ventricular spherical index 0.049 0.719 
Table 18. Correlations of echocardiographic parameters with effective regurgitant orifice area in 




Validity and reproducibility 
Inter and intra observer variations in the measurements of tricuspid annulus diameter, tethering 
area, tethering height, end-systolic eccentricity index and septal angle were assessed by 
analyzing ten random images by two independent blinded investigators and by the same 
principal investigator at separate time points. Lin’s concordance correlation coefficient was 
calculated for the observed measurements. Good correlation was observed for all the parameters 
(table 19). 
A 
Variable Lin’s concordance correlation coefficient, ρc 95 % CI 
End-diastolic tricuspid 
annulus diameter 
0.915 0.801 - 0.965 
Tethering distance 0.822 0.501 - 0.944 
Tethering area 0.823 0.466  - 0.949 
Right ventricular End- 
systolic EI# 
0.809 0.544 - 0.927 




Variable Lin’s concordance correlation coefficient, ρc 95 % CI 
End-diastolic tricuspid 
annulus diameter 
0.959 0.866 - 0.988 
Tethering distance 0.842 0.533 - 0.953 
Tethering area 0.959 0.854 - 0.989 
Right ventricular End- 
systolic EI# 
0.853 0.538 - 0.959 
Septal Angle 0.802 0.563 - 0.917 




The present study, a prospective observational study, evaluated the mechanisms and 
determinants of severity of functional TR by echocardiography. The study demonstrated that 
tricuspid valve tethering distance, end-diastolic tricuspid annulus diameter, end-systolic right 
ventricular eccentricity index and end systolic right atrial area independently determined severity 
in patients with functional TR who were referred for echocardiographic assessment with various 
clinical conditions. Right ventricular end- diastolic and end- systolic area, right ventricular FAC 
and right ventricular Tei index (reflecting right ventricular systolic function), estimated 
pulmonary artery systolic pressure, and left ventricular function did not independently determine 
functional TR severity. The strong positive correlations of tricuspid valve tethering distance, 
end-diastolic tricuspid annulus diameter and the eccentricity index with the functional TR 
severity emphasizes the importance of tricuspid valve deformations and changes in right 
ventricular geometry in the pathogenesis of this condition. 
Unlike the case with mitral regurgitation, impact of alterations of right ventricular 
morphology and function on functional TR has been less well characterized. Review of recent 
medical literature revealed only a few studies on this aspect. One of the key reasons for the lack 
of investigations on this topic could be that until recently, underlying left sided pathological 
processes were give much more importance and management was tailored to correcting them. 
However, as mentioned earlier, several recent studies have shown that functional TR progresses 
even after correction of left sided pathology in a significant proportion of patients. Another 
reason for the lack of data could be that there has been no well characterized method for 
assessing the right ventricle. As a consequence mechanisms of functional TR have not been well 
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evaluated whereas mechanisms of functional mitral regurgitation have been thoroughly 
studied.68-71 Delineation of the various mechanisms and determinants of functional TR are of 
utmost importance considering the therapeutic implications and the impact it has on the 
prognosis of various cardiac and non cardiac conditions. Recognition of importance of functional 
TR formed the impetus for the present study. 
As mentioned earlier, the normal functioning of tricuspid valve requires coordination and 
integrity of various components such as the leaflet tissue, supporting annular ring, chordae 
tendinae, papillary muscles, right atrium and right ventricular myocardium.11 Any abnormality of 
one of the above mentioned components can cause significant regurgitation. In functional TR, 
the valve leaflets are structurally normal. Tricuspid annulus dilatation and inadequate leaflet 
coaptation secondary to displacement of papillary muscles are considered to be the key 
mechanisms in the genesis of functional TR as shown in earlier studies.39,72,73 The present study 
affirmed the relationship between tricuspid annulus diameter and severity of functional TR as 
demonstrated in earlier studies.39,47,74 This study also showed that TV tethering height is another 
strong determinant of functional TR severity.  
Relationship between morphological changes of right sided chambers and functional TR 
Interestingly, pulmonary artery systolic pressure, right ventricular systolic function and 
right ventricular chamber size did not independently determine functional TR severity suggesting 
that neither pulmonary hypertension nor enlargement of right ventricle with or without systolic 
dysfunction is a pre requisite for functional TR regurgitation. However changes in right 
ventricular shape reflected by end-systolic eccentricity index appeared to be important in the 
mechanism of functional TR. Another recent study looking at atrial and ventricular factors that 
are important in the mechanism of functional TR, found spherical index of the right ventricle in 
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addition to tethering height and right atrial area, to be significantly associated with severity of 
regurgitation.48 Thus changes in right ventricular shape seem to outweigh ventricular size 
alterations in determining functional TR severity. However, right ventricular enlargement was 
shown to influence both tethering height and tricuspid annulus dimension in this study (tables 9 
and 10). 
Another parameter which was shown to determine functional TR severity in our study 
was end systolic right atrial enlargement. This is not surprising considering the anatomical 
location of tricuspid valve between the two right sided chambers. Another factor which might 
have contributed to the pathogenesis is atrial fibrillation. Severe TR group had significantly 
greater proportion of patients with atrial fibrillation secondary to the underlying left sided valve 
pathology and possible left atrial enlargement. Atrial fibrillation has been shown to cause right 
atrial dilatation with potential widening of the adjacent tricuspid annulus which can in turn result 
in significant TR. 
Determinants of tricuspid valve alterations  
 Enlargement of the TV annulus and leaflet tethering were found to be the significant 
parameters contributing to functional TR severity. Annular dilatation is postulated to contribute 
to tricuspid regurgitation by limiting the amount of leaflet overlap during valve closure. Right 
ventricular basal dimension (p < 0.001), right ventricular end systolic eccentricity index (p < 
0.001) and right atrial end-systolic area (p < 0.001) were identified as the parameters that 
independently determined end-diastolic tricuspid annulus. Tricuspid annulus is shared by the two 
right sided chambers. Thus enlargement of right sided chambers (right atrium) or alteration of its 
shape (relative dilation of the basal segment of the right ventricle) is important in determining 
tricuspid annulus dimension.  Similarly right sided chamber enlargement and changes in the 
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shape of the right ventricle (eccentric enlargement) determined tethering height. Right 
ventricular geometry changes can lead to papillary muscle displacement resulting in tethering of 
the valve leaflets. 
Role of pulmonary hypertension 
Although pulmonary artery systolic pressure correlated weakly with TR severity in the 
entire study population, it did not independently determine functional TR severity in this study. 
When patients with pulmonary hypertension (estimated PASP) were analyzed, significant 
association with TR severity was noted for tricuspid valve deformations and eccentric right 
ventricular enlargement. This suggests that remodeling of the right heart rather than the absolute 















Insights from 3-Dimensional echocardiographic assessment 
 Changes in the tricuspid annulus such as increased area and circumference of the annulus 
with the annulus assuming a relatively circular shape were observed with increasing severity of 
functional TR. A greater enlargement of the antero-posterior dimension than the septal-lateral 
dimension was noted indicating preferential enlargement of the annulus along its free wall 
(figure18). Angle between the septal tricuspid leaflet and the annulus plane showed the best 












Figure 18. Tricuspid valve viewed from the atrial side showing dilatation of the annulus along 












Tricuspid Valve viewed 
from the atrium 
Free wall dilatation 
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Comparison with other studies 
 The results of the present study were comparable with that of other studies (table 20) 







Kim et al47 Prospective  
Observational 
2-D Echo 





* TV tethering area 
* Right Ventricular End 
systolic EI# 
* End diastolic tricuspid 
annulus diameter 
Fukuda et al8 Retrospective 
2-D Echo 
216 Post tricuspid 
annuloplasty 
* TV tethering distance 
Ton-Nu et 
al12 




with at least 
moderate TR 




*Ratio of tricuspid 
annulus dimensions 
Song et al75 Observational 
3-D Echo 





* Right Ventricular inlet 
dimension  
* Right Ventricular end-
systolic volume 
 * Septal and anterior 
leaflet tenting angles 
Present study Prospective  
Observational 




Patients aged 18 







* TV tethering distance 
* Right Ventricular End 
systolic # 
* End diastolic tricuspid 
annulus diameter 
* Right atrial end systolic 
area 
Table 20. Comparison with other studies. #EI- Eccentricity index. 
To the best of our knowledge, this is the first Indian study done to evaluate the 
determinants of functional TR severity. A large proportion of our patients were rheumatic 
valvular heart disease which is in contrast to non rheumatic left sided valve lesions or heart 
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failure patients in western studies. Nevertheless, factors involved in the pathogenesis of 
functional TR are likely to be identical. When compared to the findings of the study by Kim et 
al47, we found TV tethering distance and right atrial end systolic area to determine severity. 
Three dimensional echocardiographic results of our study are in keeping with the findings of the 
study by Ton- Nu et al.12 
Feasibility 
In this study, assessment of right ventricle and tricuspid valve was done using simple two 
dimensional echocardiographic measurements. These parameters are practically easy to record 
and require only obtaining a good quality image. Recording of the images took an average of two 
minutes and measurements took average of another four minutes to complete. Offline evaluation 
of the data sets took an additional average of five minutes. Measurements obtained were valid 









Suggested Mechanisms of functional TR based on the results of the present study 
Based on the results of the study, likely mechanisms of functional TR were proposed 
(figure 19). In the initial stages, there is a selective dilatation of the basal aspect of the right 
ventricle which results in dilatation of annulus. Depending on the amount of overlap of the 
leaflets, there may or may not be regurgitation. As dilatation progresses, failure of coaptation 
increases and the degree of functional TR increases. Atrial fibrillation may contribute to 
significant right atrial enlargement. Enlarged right atrium may add to the dilatation of the 
annulus and worsen functional TR. Lastly, with eccentricity and progressive right ventricular 













Figure 19. Suggested mechanisms for functional TR based on the results of the present study 
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POTENTIAL CLINICAL IMPLICATIONS OF THE PRESENT STUDY 
As mentioned earlier functional TR is a complex clinical entity and is associated with 
significant morbidity. There has been a greater impetus to perform annuloplasty at the time of 
left heart surgery if tricuspid annulus is found to be enlarged. However with the current 
techniques, functional TR persists or even progresses in a significant proportion of patients. The 
observations of the current study have several potential clinical implications, some of which are 
listed below. 
1. A strong correlation was shown between TV tethering height, end- diastolic tricuspid annulus 
diameter and functional TR severity. Cut off values estimated could be used as additional 
supportive criteria in assessing severity of functional TR. 
2. A detailed evaluation of the tricuspid valve apparatus, including that of the tricuspid annulus 
dimension and the tethering height should be considered mandatory in patients with functional 
TR, especially those who are being considered for left heart surgery. Cut off values of end 
diastolic tricuspid annulus diameter that reliably predicted severe regurgitation was 3.59 cm. 
Current guidelines recommend tricuspid annuloplasty if diameter is greater than 4.0 cm. Our 
values suggest that cut off values for annuloplasty should be even lower especially in patients 
with rheumatic heart disease. Lower cut off values have been suggested by other studies as 
well.21,76,77 
3. This study has shown that in addition to end diastolic annulus dimension, parameters such as 
TV tethering height and eccentricity indices also contribute to TR severity. Hence, performing an 
annuloplasty may not be enough in patients who have severe tethering of the leaflets. Newer 
surgical techniques to address tethering should be developed. One such technique that is being 
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recently developed is the anterior tricuspid leaflet augmentation.78  Anterior tricuspid leaflet 
augmentation involves augmentation of the anterior leaflet with the use of an autologous 
pericardial patch followed by implantation of Carpentier–Edwards annuloplasty ring. This results 
in increased size and leaflet coaptation area, allowing better coaptation with a decreased tension 
within the ventricle.  Tricuspid valve replacement is another option for patients with severe 
tethering. 
4. Dilatation of the tricuspid annulus was found to be in the direction of free wall. Hence annuloplasty 
focussing on this aspect may help in reducing the degree of regurgitation. 
In short, observations of this study can help in clinical evaluation of functional TR in patients 
with left side valve disease and guide future research on this topic. 
FUTURE DIRECTIONS AND NEW QUESTIONS RAISED 
Future studies done with serial echocardiographic follow up may help to identify the sequential 
geometric changes of right sided chambers and tricuspid annulus in functional TR patients. This 
will help to further clarify the mechanisms involved in the pathogenesis of this condition. 
Technological innovations in 3-dimensional echocardiography with regard to acquisition, better 
imaging and analytic software may enhance the clinical application of this modality for the 
assessment of the TV.   
Factors involved in the mechanism of tricuspid regurgitation after surgical procedures such as 
annuloplasty were not assessed in the present study. Future three dimensional echocardiographic 
studies may play a greater role in identifying mechanisms and factors that determine severity in 
patients who develop regurgitation after tricuspid annuloplasty. 
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STRENGTHS AND LIMITATIONS OF THE PRESENT STUDY 
Strengths of the study: Following were considered to be the strengths of the study. 
The present study was a prospectively conducted observational study with data likely to 
represent real patient population in clinical practice. 
Limitations: Several limitations should be acknowledged in the present study, many of which 
are primarily related to the echocardiographic measurements. Some of the key limitations are 
stated below.  
1. Because of the complex shape and highly trabeculated nature of the right ventricle, 
accurate estimation of the right ventricular function and size are difficult to make with the 
currently available two dimensional imaging techniques. Right ventricular imaging is highly 
dependent on transducer position. Hence for the purpose of this study, only patients with good 
echocardiographic window were included and the right ventricular measurements were done 
from the apical four chamber window. Even then, it is possible some amount of error might have 
occurred while measuring some of these parameters. 
2. A significantly high number of patients with rheumatic heart disease as the etiology of 
the left sided valve lesion were present in our study. Even though substantial care was taken to 
exclude patients with organic rheumatic tricuspid valve involvement, it is possible that patients 
with minimal rheumatic involvement were included. However this error is likely to be negligible 
as previous reports have shown 2-dimensional echocardiography to be useful in evaluating 
rheumatic etiology of tricuspid valve diseases.79 
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3. The grading of tricuspid regurgitation is often considered to be highly subjective and 
there is no perfect standard for classifying functional TR. Also severity of regurgitation is likely 
to vary depending on the respiratory changes, loading conditions and contractility. In this study, 
severity of functional TR was graded incorporating several parameters prescribed by various 
guidelines. Also, values of the parameters in this study were averaged over three cycles for sinus 
rhythm and five cycles for atrial fibrillation.  
4. Serial echocardiographic follow up was not part of the study design and hence one may 
argue to comment whether right sided chamber enlargement is the result or cause of functional 
TR. Functional TR can be thought of as a vicious remodeling cycle in which TR leads to right 
ventricular remodeling which in turn leads to further worsening of TR. Kim et al47 observed a 
lack of eccentric right ventricular enlargement in patients with chronic right ventricular dilatation 
due to TR associated with organic pathology such as chordal rupture. This suggests that change 
in right ventricular geometry change is not the result, but the cause of functional TR. 
5. Limitations of 2-dimensional echocardiography in assessing complex three 
dimensional structures like the right ventricle are well known.  However three dimensional 
imaging of the right ventricle is still limited by technical problems and assessment of datasets 







 Main findings of the present study are summarized below. 
 Tricuspid valve tethering distance, end-diastolic tricuspid annulus dimension, end-
systolic eccentricity index and end-systolic right atrial area independently determine 
severity of functional TR 
 Tricuspid annulus end diastolic diameter value of > 3.59 cm and tethering distance > 
0.79 cm predicted patients with more than moderate functional TR reliably 
 Right ventricular basal dimension, right atrial end-systolic area and right ventricular 
end systolic eccentricity index determine end diastolic tricuspid annulus dimension 
 Right ventricular end-diastolic area, right atrial end-systolic area and right ventricular 
end systolic eccentricity index determine tricuspid valve tethering height 
 End diastolic tricuspid annulus dimension and tethering height were the determinants 
of severity in patients with pulmonary artery hypertension. 
 With increasing severity of functional TR, tricuspid annulus assumes a relatively 
circular shape with greater increase in the antero-posterior annulus dimension.  
 Degree of tethering was found to correlate with functional TR severity in all three 
leaflets. Angle between septal leaflet and tricuspid annulus plane correlated best with 
severity. 
   This study emphasizes the role of tricuspid annulus dilatation and TV leaflet tethering in 
the pathogenesis of functional TR. Geometric alterations of the right atrium and right ventricle 
contributes significantly to the development of functional TR. Findings of this study have 
potential mechanistic and therapeutic implications. 
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MASTER DATA SHEET 
Patients 
 
Name ID Age Sex Height Weight BSA Rhythm RVmid RVBasal RVlong RVEDA RVESA RVFAC 
1.  
Sangeetha 647745 20 2 151 42 1.34 1.00 3.10 3.90 5.20 15.40 8.00 48.05 
2.  
Nazeera 267142 22 2 157 45 1.42 1.00 3.40 4.40 7.00 26.60 15.11 43.20 
3.  
Krishnakumar 818989 18 1 130 22 .91 1.00 2.60 3.00 4.90 11.35 5.90 48.02 
4.  
Sarath Kumar 190237 18 1 160 48 1.48 1.00 3.50 4.10 6.30 19.80 11.20 43.43 
5.  
Zamruth 873457 53 2 146 50 1.40 1.00 2.90 4.00 6.30 13.70 7.26 47.01 
6.  
Malarkodi 472714 35 2 155 59 1.57 2.00 2.20 4.10 6.10 17.30 10.10 41.62 
7.  
Anbu Kumar 540013 37 1 165 51 1.55 1.00 2.70 4.10 6.70 17.69 10.80 38.95 
8.  
Rani P 421394 51 2 163 54 1.57 2.00 2.00 2.60 6.29 13.00 8.10 37.69 
9.  
Sulochana 447797 34 2 148 38 1.26 1.00 3.60 4.70 6.96 24.86 16.70 32.82 
10.  
Rogini 834512 45 2 144 41 1.28 1.00 2.90 4.40 5.40 14.50 8.10 44.14 
11.  
Senthil S 817686 30 1 161 48 1.48 1.00 3.40 4.09 7.01 17.43 10.47 39.93 
12.  
Valli 829150 40 2 154 50 1.46 1.00 2.60 3.52 5.36 13.10 7.07 46.03 
13.  
Nurul Hoda 789507 72 1 172 64 1.76 1.00 3.10 3.90 5.82 17.00 10.10 40.59 
14.  
Kumari Bai 718782 20 2 150 38 1.27 1.00 2.93 4.20 5.70 15.90 8.94 43.77 
15.  
Shamim Akhtar 801553 48 1 173 73 1.87 1.00 2.70 3.40 5.90 15.00 9.00 40.00 
16.  
Kothandan M 201397 46 1 156 45 1.41 1.00 2.50 3.90 6.39 13.80 7.90 42.75 
17.  
Narendranath 811291 81 1 163 44 1.44 1.00 3.32 4.50 6.58 20.10 11.10 44.78 
18.  
Vijaya 097264 18 2 156 41 1.35 1.00 3.17 4.27 6.51 22.90 15.80 31.00 
19.  
Shantha 507139 44 2 157 41 1.36 2.00 2.52 2.91 5.92 15.80 8.22 47.97 
20.  
Govindammal 589740 66 2 160 49 1.49 2.00 2.54 3.65 5.34 15.70 9.20 41.40 
21.  
Arun Kumar 840116 46 1 171 51 1.59 1.00 3.60 4.50 6.80 20.73 13.10 36.81 
22.  
ShantiRanjan 839059 46 1 154 55 1.52 1.00 2.63 3.42 6.00 14.39 6.86 52.33 
23.  
Bula Kumar 851332 48 2 145 35 1.20 1.00 2.57 3.61 7.58 17.30 9.30 46.24 
24.  
Subash 945209 18 1 154 38 1.30 1.00 2.86 3.85 5.75 15.30 7.86 48.63 
25.  
Palani 757166 18 1 144 28 1.09 1.00 3.35 4.22 6.05 16.30 8.83 45.83 
26.  
Shenbagam 854585 20 2 158 38 1.32 1.00 2.75 3.97 5.84 16.50 10.90 33.94 
27.  
Mathiur Rahman 854138 34 1 177 63 1.78 2.00 2.02 3.50 6.96 17.60 11.00 37.50 
28.  
unnamalai 485997 33 2 153 57 1.54 1.00 2.98 3.74 6.85 17.60 12.00 31.82 
29.  
Parimala 971158 44 2 154 58 1.56 1.00 1.80 2.77 4.88 11.10 5.69 48.74 
30.  
Prabha 057218 38 2 154 47 1.42 1.00 2.01 3.18 6.39 15.70 8.31 47.07 
31.  
Adi Narayan 855044 70 1 156 48 1.45 1.00 2.66 5.37 7.71 25.90 13.30 48.65 
32.  
Govindamma 291495 50 2 152 54 1.49 1.00 2.50 3.70 7.37 16.00 11.00 31.25 
33.  
Tamilarasi 118763 22 2 168 49 1.54 1.00 3.55 4.59 6.92 23.00 13.20 42.61 
34.  
Sudhir 814510 36 1 163 50 1.52 1.00 3.42 4.66 7.40 18.00 11.10 38.33 
35.  
Dhanabackiam 647567 29 2 161 51 1.52 1.00 3.55 4.83 7.60 24.22 19.00 21.55 
36.  
Lakshmi 806089 55 2 153 47 1.42 2.00 3.06 4.08 6.90 17.07 9.76 42.82 
37.  
Selvakumar 714070 21 1 163 52 1.55 1.00 3.50 4.10 6.80 17.10 9.56 44.09 
38.  
Vijayakanth 809117 22 1 173 51 1.60 1.00 3.00 3.90 7.40 18.00 9.00 50.00 
39.  
Lalitha 367403 58 2 146 44 1.33 1.00 3.90 5.30 7.70 22.80 14.80 35.09 
40.  
Neelammal 797740 52 2 153 39 1.31 1.00 4.10 4.80 5.40 23.50 15.00 36.17 
41.  
Mamata Mondal 020388 38 2 156 32 1.22 1.00 3.40 4.16 6.21 18.60 12.10 34.95 
42.  
Shenbagavalli 880655 30 2 161 44 1.43 1.00 2.70 3.40 5.00 16.00 11.00 31.25 
43.  
Ponnuswamy 790998 66 1 165 50 1.53 1.00 2.70 3.80 6.10 19.00 12.00 36.84 
44.  
Karumbathi 699238 38 1 164 60 1.65 2.00 3.20 3.90 7.00 25.30 15.60 38.34 
45.  
Udayakumar P 394476 28 1 172 52 1.61 1.00 3.00 4.30 7.20 21.90 14.50 33.79 
46.  
Rani V 782418 56 2 150 34 1.22 2.00 2.90 4.60 6.35 18.30 9.61 47.49 
47.  
Rajeswari 106439 18 2 147 39 1.27 1.00 3.60 5.30 6.30 19.87 11.74 40.92 
48.  
Shova Sinha 936278 49 2 150 65 1.60 2.00 2.20 4.05 6.34 13.76 7.94 42.30 
49.  
Selva Kumari 180539 37 2 159 46 1.44 1.00 3.70 4.97 6.08 18.70 10.85 41.98 
50.  
Sivagami 133394 32 2 153 29 1.15 2.00 2.10 2.70 5.36 11.84 7.13 39.78 
51.  
Saroj Yadav 833349 40 2 153 53 1.49 2.00 3.10 3.70 6.10 16.80 8.70 48.21 
52.  
Jebamani 691869 34 2 141 51 1.38 1.00 2.64 3.62 6.35 17.52 9.54 45.55 
53.  
Malar 188131 39 2 155 50 1.47 2.00 3.40 4.10 6.01 15.56 9.18 41.00 
54.  
Selvam 122287 35 1 163 65 1.72 1.00 4.19 5.00 8.30 31.00 20.19 34.87 
55.  
Jaikishan 802242 65 1 167 43 1.45 2.00 2.80 3.10 6.60 15.00 10.96 26.93 
56.  
Kannammal 987375 35 2 153 67 1.65 2.00 2.35 3.73 6.26 13.70 8.84 35.47 
57.  
Rose 254826 39 2 153 45 1.39 2.00 2.57 3.74 5.60 15.90 11.40 28.30 
58.  
Rizwanullah 055663 59 1 170 70 1.81 2.00 3.54 4.41 7.62 23.80 14.90 37.39 
59.  
Deviakiammal 853702 74 2 156 42 1.37 2.00 2.51 3.93 5.97 17.20 10.30 40.12 
60.  
Ramkumar 858695 36 1 154 41 1.34 1.00 2.90 4.00 5.18 15.00 10.30 31.33 
61.  
Rajeswari 991737 35 2 152 50 1.45 1.00 2.47 3.32 6.05 14.30 8.30 41.96 
62.  
Raji 793469 51 2 138 43 1.26 2.00 2.32 3.59 5.62 15.10 8.67 42.58 
63.  
Boobalan 838975 31 1 165 55 1.60 1.00 5.58 3.49 6.66 26.10 16.50 36.78 
64.  
Prema 904545 40 2 160 67 1.32 2.00 4.98 6.10 7.80 29.81 17.10 42.64 
65.  
Shyamal Patra 803969 39 1 167 59 1.66 1.00 4.10 5.30 8.45 34.40 24.16 29.77 
66.  
Vamathi 386556 38 2 153 61 1.58 2.00 3.30 4.10 6.95 23.30 13.90 40.34 
67.  
Nila Khatun 812113 26 2 161 52 1.53 2.00 3.50 5.10 7.10 25.70 15.20 40.86 
68.  
Deepti 814183 49 2 152 38 1.29 2.00 3.90 5.70 6.80 30.86 19.73 36.07 
69.  
Govindaraj 573966 79 1 172 48 1.55 2.00 3.20 3.70 6.40 17.00 9.70 42.94 
70.  
Veena Devi 812433 45 2 152 34 1.23 2.00 3.32 4.56 6.90 20.40 11.80 42.16 
71.  
Ananda Paul 953948 52 1 160 52 1.53 1.00 4.80 6.40 7.80 37.43 24.70 34.01 
72.  
Uthirakumar 773446 22 1 168 59 1.67 1.00 3.80 5.40 6.30 24.40 13.80 43.44 
73.  
Selvi 806969 35 2 158 55 1.55 1.00 4.30 5.10 8.20 35.00 23.70 32.29 
74.  
Simson Mochar 795883 58 1 165 43 1.44 1.00 4.20 5.50 7.30 29.00 18.80 35.17 
75.  
Harlin Rongha 770812 30 1 171 61 1.71 2.00 5.20 6.50 8.10 41.90 25.10 40.10 
76.  
Kalpana 815920 30 2 130 41 1.19 1.00 3.80 4.80 7.10 26.00 20.10 22.69 
77.  
Kamatchi 586712 56 2 155 65 1.64 2.00 3.40 4.90 6.90 25.03 15.50 38.07 
78.  
Anowar Bibi 789661 34 2 149 43 1.34 2.00 2.80 3.80 4.70 20.40 16.80 17.65 
79.  
Stella 601286 45 2 146 33 1.18 2.00 3.20 4.10 5.70 17.10 12.00 29.82 
80.  
Ramamurthy 423256 46 1 163 62 1.67 1.00 4.10 5.60 7.70 26.34 17.49 33.60 
81.  
Samsuddin Ansari 822130 45 1 144 44 1.32 1.00 3.10 4.70 6.80 18.32 13.10 28.49 
82.  
Sasipriya 824669 28 2 156 41 1.35 1.00 6.40 6.40 7.40 38.70 26.75 30.88 
83.  
Mamata Layek 772526 46 2 152 47 1.41 1.00 3.80 5.40 7.70 25.20 16.80 33.33 
84.  
Palani 936065 36 1 164 58 1.63 2.00 3.50 5.10 6.40 21.20 11.00 48.11 
85.  
Rani A 921834 54 2 150 37 1.26 2.00 5.00 6.70 8.05 42.90 28.00 34.73 
86.  
Sarada Devi 356600 37 2 157 47 1.44 2.00 3.51 4.50 5.20 16.70 9.30 44.31 
87.  
Kapuri Devi 651668 53 2 145 40 1.27 2.00 3.05 4.20 7.10 22.00 12.02 45.36 
88.  
Rani 836152 55 2 153 73 1.71 1.00 3.20 4.50 6.80 19.30 11.10 42.49 
89.  
Arup Middya 219451 36 1 158 57 1.57 1.00 3.86 5.36 7.45 29.70 21.10 28.96 
90.  
Janaki 329307 50 2 148 57 1.50 2.00 3.50 4.70 6.40 26.36 13.30 49.54 
91.  
Tapan Dutta 837082 51 1 158 65 1.66 1.00 3.80 4.80 6.90 25.10 18.00 28.29 
92.  
Jegan 925961 19 1 172 46 1.53 1.00 5.20 6.90 7.68 57.01 46.39 18.63 
93.  
Nagarani K 803520 30 2 142 43 1.29 1.00 3.20 3.80 7.00 17.11 11.78 31.15 
94.  
Usha 453241 39 2 150 40 1.30 2.00 3.30 4.80 6.70 18.00 11.79 34.50 
95.  
Mani 054550 45 1 163 47 1.48 2.00 3.65 5.02 8.53 34.22 22.30 34.83 
96.  
Jegadeesan 147654 44 1 163 60 1.64 1.00 3.90 5.40 6.88 28.76 14.74 48.75 
97.  
Navamani 664841 64 2 140 40 1.24 1.00 3.55 4.78 5.51 19.20 11.16 41.88 
98.  
Rajakumari 807061 37 2 146 35 1.21 1.00 4.30 5.26 6.80 29.80 19.80 33.56 
99.  
Poongavanam 629747 56 2 155 42 1.36 2.00 3.52 5.39 5.81 18.50 10.90 41.08 
100. 
Md Yacob 466714 55 1 166 57 1.63 2.00 3.60 4.60 6.40 18.14 10.85 40.19 
101. 
Nirmala Maji 711006 56 2 142 42 1.28 2.00 4.30 6.90 7.40 32.50 19.80 39.08 
102. 
Pushpa Bala 037380 70 2 137 40 1.22 2.00 3.54 5.69 8.04 33.10 15.80 52.27 
103. 
Kishun Saw 854086 28 1 173 47 1.55 1.00 4.48 6.60 7.38 40.80 30.30 25.74 
104. 
Roshin Bauri 851557 57 2 145 44 1.32 1.00 4.50 5.89 7.44 36.40 25.30 30.49 
105. 
Sakthivelmurugan 805006 33 1 154 48 1.43 2.00 3.60 5.90 6.36 20.60 14.60 29.13 
106. 
Shahabaz Alam 818185 15 1 156 34 1.25 1.00 4.60 5.40 7.34 38.40 32.30 15.89 
107. 
Devaki 428989 44 2 157 58 1.58 2.00 3.10 4.20 7.10 22.00 15.00 31.82 
108. 
Swapan Pal 726332 42 1 170 54 1.62 2.00 3.76 5.08 5.90 25.20 14.10 44.05 
109. 
Subramani K 423622 65 1 163 55 1.58 2.00 3.70 4.90 6.50 25.00 15.00 40.00 
110. 
Uma 467241 30 2 153 53 1.49 2.00 3.56 4.92 6.98 25.10 19.70 21.51 
 
  




Sangeetha 647745 .52 3.33 4.20 2.40 12.10 2.30 2.80 17.86 2.20 .85 .80 337.00 
2. 
Nazeera 267142 .46 3.60 5.10 4.70 18.00 2.88 3.26 11.66 2.23 1.15 .76 447.00 
3. 
Krishnakumar 818989 .40 2.31 3.60 2.70 13.10 1.60 2.16 25.93 2.04 .51 .58 357.00 
4. 
Sarath Kumar 190237 .53 3.60 4.40 3.30 12.20 2.20 2.50 12.00 2.13 .47 .44 228.00 
5. 
Zamruth 873457 .45 2.31 4.50 3.70 14.80 2.30 3.00 23.33 2.34 .54 .52 269.00 
6. 
Malarkodi 472714 .47 2.50 4.90 3.90 19.10 2.60 3.10 16.13 1.70 .72 .36 276.00 
7. 
Anbu Kumar 540013 .56 2.50 4.35 3.44 15.31 2.70 3.05 11.48 2.12 .68 .55 320.00 
8. 
Rani P 421394 .49 6.07 5.50 2.70 17.20 2.20 2.80 21.43 1.60 .38 .28 424.00 
9. 
Sulochana 447797 .59 2.86 4.50 4.40 14.80 2.50 2.87 12.89 1.95 1.00 .67 330.00 
10. 
Rogini 834512 .63 2.29 4.60 2.70 17.70 2.60 3.26 20.25 2.08 .81 .45 312.00 
11. 
Senthil S 817686 .74 3.13 4.60 3.00 11.20 2.45 3.05 19.67 2.60 .60 .45 277.00 
12. 
Valli 829150 .46 2.31 3.60 2.70 8.33 2.07 2.40 13.75 1.80 .42 .41 223.00 
13. 
Nurul Hoda 789507 .48 1.28 4.20 3.60 20.10 2.30 2.70 14.81 2.20 .95 .56 407.00 
14. 
Kumari Bai 718782 .42 5.94 5.30 3.85 20.40 2.10 2.67 21.35 1.76 .48 .30 346.00 
15. 
Shamim Akhtar 801553 .68 3.33 4.80 3.90 18.10 2.20 2.76 20.29 2.21 .68 .43 254.00 
16. 
Kothandan M 201397 .49 2.31 3.30 3.00 15.10 2.10 2.38 11.76 2.70 .67 .43 274.00 
17. 
Narendranath 811291 .44 5.71 3.60 3.30 13.80 3.02 3.36 10.12 2.16 1.20 .50 257.00 
18. 
Vijaya 097264 .70 3.81 4.80 3.53 16.10 2.84 3.18 10.69 2.25 .56 .43 358.00 
19. 
Shantha 507139 .49 3.75 4.50 3.90 14.80 2.41 2.72 11.40 1.89 .55 .30 261.00 
20. 
Govindammal 589740 .61 4.29 5.70 2.80 17.80 2.46 2.76 10.87 1.56 .46 .21 254.00 
21. 
Arun Kumar 840116 .54 5.24 4.40 3.40 12.33 2.65 3.25 18.46 2.16 .68 .46 259.00 
22. 
ShantiRanjan 839059 .44 3.71 3.62 2.64 11.10 2.30 2.70 14.81 1.97 .91 .40 309.00 
23. 
Bula Kumar 851332 .52 3.81 5.24 3.86 17.20 2.30 2.83 18.73 2.40 .72 .44 311.00 
24. 
Subash 945209 .56 2.64 4.50 2.62 9.08 2.71 3.20 15.31 2.46 .63 .29 263.00 
25. 
Palani 757166 .51 4.64 3.83 3.79 16.70 2.56 2.92 12.33 2.38 .42 .10 292.00 
26. 
Shenbagam 854585 .62 3.21 4.02 2.77 10.40 2.38 2.64 9.85 2.40 1.45 .57 274.00 
27. Mathiur 
Rahman 854138 .65 5.00 4.80 3.26 14.30 2.55 3.31 22.96 2.36 .52 .41 341.00 
28. 
unnamalai 485997 .68 2.81 3.88 2.94 12.80 2.10 2.50 16.00 2.38 .60 .43 258.00 
29. 
Parimala 971158 .51 4.29 4.31 2.07 14.80 2.52 2.78 9.35 2.34 1.06 .47 290.00 
30. 
Prabha 057218 .48 2.83 4.30 2.83 11.60 2.07 2.61 20.69 2.72 .62 .46 333.00 
31. 
Adi Narayan 855044 .61 2.17 5.30 4.93 21.10 2.89 3.32 12.95 2.03 1.29 .59 324.00 
32. 
Govindamma 291495 .62 1.79 3.80 3.20 17.10 2.30 2.56 10.16 2.13 .98 .45 309.00 
33. 
Tamilarasi 118763 .42 2.86 4.60 3.30 16.80 2.28 2.58 11.63 2.15 .71 .49 326.00 
34. 
Sudhir 814510 .55 3.21 5.60 4.70 21.56 2.74 3.56 23.03 2.70 1.80 .88 312.00 
35. 
Dhanabackiam 647567 .50 4.06 5.80 4.60 18.80 2.80 3.30 15.15 1.51 .87 .69 363.00 
36. 
Lakshmi 806089 .50 5.71 6.42 5.20 24.30 3.08 3.63 15.15 2.07 .80 1.11 244.00 
37. 
Selvakumar 714070 .58 4.76 4.40 3.83 17.90 2.72 3.05 10.82 2.37 .93 .60 311.00 
38. 
Vijayakanth 809117 .47 3.13 4.50 3.40 14.10 2.90 3.30 12.12 2.30 .78 .66 248.00 
39. 
Lalitha 367403 .52 3.57 5.90 5.30 20.30 2.89 3.37 14.24 1.80 1.59 .78 350.00 
40. 
Neelammal 797740 .56 2.40 4.80 4.70 18.10 2.80 3.40 17.65 1.60 1.35 .84 495.20 
41. 
Mamata Mondal 020388 .52 3.57 3.80 3.40 14.20 2.26 2.56 11.72 2.10 .98 .64 374.00 
42. 
Shenbagavalli 880655 .93 5.20 3.60 3.30 13.83 2.70 3.10 12.90 2.20 .98 .50 238.00 
43. 
Ponnuswamy 790998 .49 4.64 4.70 3.80 16.40 2.98 3.38 11.83 2.04 .87 .74 249.00 
44. 
Karumbathi 699238 .53 4.40 5.70 3.80 18.00 2.90 3.44 15.70 1.97 .99 .77 367.80 
45. 
Udayakumar P 394476 .61 4.64 5.70 4.90 21.10 2.53 3.27 22.63 2.00 .96 .77 343.00 
46. 
Rani V 782418 .59 2.31 5.40 3.80 18.80 2.90 3.37 13.95 1.74 1.04 .59 322.00 
47. 
Rajeswari 106439 .69 4.06 5.80 3.10 17.78 2.60 3.08 15.58 1.60 .76 .47 478.00 
48. 
Shova Sinha 936278 .44 3.85 4.80 4.70 19.72 2.69 3.20 15.94 2.14 .50 .37 328.00 
49. 
Selva Kumari 180539 .42 4.00 4.50 3.70 17.80 2.94 3.35 12.24 2.38 1.70 .77 406.00 
50. 
Sivagami 133394 .47 4.64 5.00 3.80 19.89 2.46 2.92 15.75 1.32 .60 .50 337.00 
51. 
Saroj Yadav 833349 .51 2.05 7.69 3.84 26.10 3.07 3.37 8.90 2.04 1.93 1.01 345.00 
52. 
Jebamani 691869 .37 2.38 4.70 3.50 16.80 2.91 3.46 15.90 2.27 1.41 .78 358.00 
53. 
Malar 188131 .70 3.43 5.00 4.30 19.50 2.56 3.29 22.19 1.90 .98 .57 269.00 
54. 
Selvam 122287 .56 2.81 5.57 4.77 21.91 3.26 3.52 7.39 1.91 2.16 1.12 265.00 
55. 
Jaikishan 802242 .60 2.42 6.60 3.50 19.90 2.50 2.90 13.79 1.29 1.13 .50 400.00 
56. 
Kannammal 987375 .63 3.41 5.58 4.69 21.90 2.56 3.05 16.07 1.81 1.21 .59 246.00 
57. 
Rose 254826 .93 5.63 6.50 4.51 20.90 2.70 3.23 16.41 1.70 .83 .61 317.00 
58. 
Rizwanullah 055663 .54 3.93 5.39 5.02 26.40 3.10 3.48 10.92 2.01 1.80 .69 352.00 
59. 
Deviakiammal 853702 .47 2.86 5.53 4.24 17.30 3.01 3.66 17.76 1.80 .69 .43 320.00 
60. 
Ramkumar 858695 .88 2.50 3.98 3.91 18.10 3.16 3.72 15.05 2.20 1.05 .53 334.00 
61. 
Rajeswari 991737 .77 2.92 4.00 3.60 17.10 2.60 3.12 16.67 2.12 1.12 .60 354.00 
62. 
Raji 793469 .74 2.62 5.29 2.83 21.20 2.22 2.59 14.29 1.85 1.33 .76 421.00 
63. 
Boobalan 838975 .72 3.48 5.34 4.95 20.80 3.06 3.48 12.07 2.11 1.85 .71 377.00 
64. 
Prema 904545 .59 2.14 6.90 6.25 37.78 3.17 3.88 18.30 2.30 2.27 1.29 252.00 
65. 
Shyamal Patra 803969 .53 2.00 6.20 4.50 23.10 3.56 4.10 13.17 1.48 2.45 1.37 383.00 
66. 
Vamathi 386556 .45 2.00 6.75 5.20 23.50 3.20 4.18 23.44 1.81 2.43 1.42 373.30 
67. 
Nila Khatun 812113 .57 5.00 6.00 3.40 19.24 3.00 3.70 18.92 1.90 1.69 1.10 352.00 
68. 
Deepti 814183 .64 2.80 7.70 5.30 31.80 2.98 3.62 17.68 2.04 1.66 1.09 509.00 
69. 
Govindaraj 573966 .62 2.81 7.50 5.90 37.30 3.70 4.40 15.91 2.30 1.21 .90 391.00 
70. 
Veena Devi 812433 .57 4.10 6.60 3.80 21.29 3.30 3.99 17.29 2.25 1.37 .80 357.00 
71. 
Ananda Paul 953948 .48 2.29 6.00 4.90 24.58 3.84 4.48 14.29 2.37 1.99 1.09 343.40 
72. 
Uthirakumar 773446 .60 2.65 6.70 5.60 29.50 3.50 4.11 14.84 2.10 2.81 1.36 252.00 
73. 
Selvi 806969 .76 2.86 6.50 6.00 27.60 2.96 3.86 23.32 1.80 1.95 1.16 456.10 
74. 
Simson Mochar 795883 .53 4.05 5.30 5.00 22.90 2.98 3.80 21.58 2.37 2.45 1.10 343.00 
75. 
Harlin Rongha 770812 .10 2.05 7.70 6.00 35.00 3.80 4.42 14.03 2.12 3.10 1.70 457.00 
76. 
Kalpana 815920 .81 1.28 5.60 3.80 19.40 2.82 3.58 21.23 1.32 1.47 1.10 565.00 
77. 
Kamatchi 586712 .52 3.13 6.10 5.05 28.17 3.70 4.39 15.72 1.90 2.63 1.22 259.00 
78. 
Anowar Bibi 789661 .58 1.79 6.30 4.50 24.16 3.50 4.02 12.94 1.30 2.24 1.30 387.00 
79. 
Stella 601286 .60 5.00 5.10 4.00 18.30 2.90 3.66 20.77 1.30 1.13 .80 370.00 
80. 
Ramamurthy 423256 .69 1.51 6.00 5.70 25.60 3.55 4.29 17.25 1.87 1.94 1.26 394.40 
81. Samsuddin 
Ansari 822130 .62 2.14 4.70 4.60 19.20 3.18 4.07 21.87 1.20 2.89 1.70 346.00 
82. 
Sasipriya 824669 .94 1.88 6.00 5.80 34.90 3.50 4.00 12.50 1.59 2.36 1.48 456.00 
83. 
Mamata Layek 772526 .89 1.71 6.10 5.70 29.95 4.09 4.40 7.05 1.31 2.42 1.13 248.00 
84. 
Palani 936065 .58 4.00 7.50 4.40 47.79 4.30 5.10 15.69 1.51 1.60 .89 337.00 
85. 
Rani A 921834 .56 3.33 7.40 7.20 38.51 5.06 5.50 8.00 1.81 4.11 1.60 250.00 
86. 
Sarada Devi 356600 .57 3.13 7.80 5.30 33.90 3.70 4.34 14.75 1.60 2.45 .75 290.00 
87. 
Kapuri Devi 651668 .54 2.44 4.70 4.50 24.50 4.20 4.80 12.50 1.87 2.05 1.00 318.00 
88. 
Rani 836152 .70 3.13 6.20 4.60 25.48 3.58 4.29 16.55 2.03 2.28 1.17 295.00 
89. 
Arup Middya 219451 .69 2.86 5.18 4.63 20.42 3.88 4.24 8.49 1.80 2.36 1.28 361.00 
90. 
Janaki 329307 .51 3.14 6.10 5.50 30.12 3.78 4.10 7.80 2.20 2.60 1.14 326.00 
91. 
Tapan Dutta 837082 .59 1.79 4.20 4.20 16.90 3.50 3.90 10.26 1.36 2.04 1.07 423.00 
92. 
Jegan 925961 .77 .50 7.03 7.01 43.10 3.88 4.34 10.60 1.21 2.70 .89 461.00 
93. 
Nagarani K 803520 .52 2.00 5.60 4.00 23.10 3.50 4.00 12.50 1.41 1.54 .95 388.00 
94. 
Usha 453241 .86 2.81 8.20 5.54 31.60 3.10 3.98 22.11 .60 1.44 .96 377.00 
95. 
Mani 054550 .51 4.33 7.30 5.80 31.96 3.58 4.02 10.95 2.03 2.56 1.03 345.00 
96. 
Jegadeesan 147654 .55 2.56 5.40 4.40 20.79 3.87 4.36 11.24 2.12 3.89 1.39 360.00 
97. 
Navamani 664841 .70 .28 5.52 5.17 22.90 3.02 3.60 16.11 1.51 1.31 .73 430.00 
98. 
Rajakumari 807061 .86 2.56 4.70 3.90 14.68 3.10 3.66 15.30 1.85 2.10 1.13 521.00 
99. 
Poongavanam 629747 .40 1.56 7.90 7.80 56.60 3.91 4.38 10.73 1.26 3.24 .87 465.00 
100.
Md Yacob 466714 .47 4.76 4.80 4.30 17.40 3.34 3.86 13.47 2.03 1.76 .85 364.00 
101.
Nirmala Maji 711006 .58 2.39 7.20 6.90 45.73 4.20 4.70 10.64 2.37 2.94 .95 244.00 
102.
Pushpa Bala 037380 .62 4.64 6.10 5.16 25.70 3.66 4.31 15.08 2.46 2.41 .97 387.00 
103.
Kishun Saw 854086 .92 1.74 6.23 6.20 32.20 3.39 3.97 14.61 1.64 3.27 1.79 467.00 
104.
Roshin Bauri 851557 .84 2.19 5.02 5.01 24.60 3.42 4.13 17.19 1.47 3.22 1.56 421.00 
105. Sakthivelmuru
gan 805006 .55 3.14 5.90 5.42 24.40 4.14 4.66 11.16 1.41 1.97 .88 416.00 
106.
Shahabaz Alam 818185 .59 1.43 6.20 4.80 22.85 3.34 3.80 12.11 1.40 1.59 1.13 491.00 
107.
Devaki 428989 .62 1.60 7.00 4.50 25.10 3.40 3.90 12.82 1.40 1.41 .98 570.00 
108.
Swapan Pal 726332 .61 2.80 8.59 6.70 43.40 4.13 4.54 9.03 1.74 3.14 1.18 271.00 
109.
Subramani K 423622 .66 3.71 6.60 5.20 32.10 3.85 4.49 14.25 1.46 3.35 1.19 341.00 
110.



















velocity EROA VC LVLong LVEDV LVESV LVEF IVC 
1. 
Sangeetha 647745 45.00 2.36 19.50 1.00 64.00 3.17 .27 6.38 78.60 32.20 59.03 1.06 
2. 
Nazeera 267142 80.00 3.45 19.17 1.00 63.00 9.16 .42 7.10 95.00 39.00 58.95 1.51 
3. 
Krishnakumar 818989 51.00 2.40 18.32 1.00 95.00 15.81 .28 6.72 120.00 47.40 60.50 1.26 
4. 
Sarath Kumar 190237 21.00 1.32 10.82 1.00 51.00 10.86 .34 6.62 72.00 30.00 58.33 1.18 
5. 
Zamruth 873457 28.00 2.76 18.65 1.00 60.00 8.32 .41 7.10 86.00 34.00 60.47 1.36 
6. 
Malarkodi 472714 30.00 3.61 18.90 1.00 81.00 10.12 .33 7.90 108.00 48.00 55.56 1.36 
7. 
Anbu Kumar 540013 40.90 2.11 13.78 1.00 64.00 6.12 .23 7.22 159.00 109.00 31.45 1.50 
8. 
Rani P 421394 72.00 3.36 19.53 1.00 76.00 3.58 .31 6.84 89.00 36.00 59.55 2.12 
9. 
Sulochana 447797 43.50 1.72 11.62 1.00 66.00 5.28 .33 7.17 61.20 23.00 62.42 1.60 
10. 
Rogini 834512 39.00 3.53 19.94 1.00 51.00 3.88 .22 6.78 107.50 47.40 55.91 1.47 
11. 
Senthil S 817686 30.67 1.56 13.93 1.00 70.00 5.04 .20 8.80 73.40 31.40 57.22 1.56 
12. 
Valli 829150 20.00 1.20 14.41 1.00 73.00 7.30 .20 5.81 67.10 28.50 57.53 1.50 
13. 
Nurul Hoda 789507 66.00 3.98 19.80 1.00 93.00 3.08 .20 6.10 114.40 49.50 56.73 2.00 
14. 
Kumari Bai 718782 48.00 4.06 19.90 1.00 43.00 9.87 .18 5.94 67.90 27.50 59.50 1.21 
15. 
Shamim Akhtar 801553 27.00 3.60 19.89 1.00 68.60 6.86 .20 6.70 105.40 43.60 58.63 1.56 
16. 
Kothandan M 201397 30.00 3.00 19.87 1.00 58.00 5.15 .17 7.82 263.70 180.00 31.74 1.50 
17. 
Narendranath 811291 26.00 2.48 17.97 1.00 71.90 7.24 .23 6.50 73.40 31.90 56.54 1.67 
18. 
Vijaya 097264 51.00 1.56 9.69 1.00 116.00 12.45 .26 7.16 79.00 32.00 59.49 1.65 
19. 
Shantha 507139 27.00 1.15 7.77 1.00 75.00 4.20 .16 5.30 84.00 32.60 61.19 1.11 
20. 
Govindammal 589740 26.00 1.21 6.80 1.00 48.90 9.87 .25 5.50 98.60 40.90 58.52 1.30 
21. 
Arun Kumar 840116 27.00 2.45 19.87 1.00 64.00 7.18 .28 6.96 83.50 35.60 57.37 1.25 
22. 
ShantiRanjan 839059 38.00 2.10 18.92 1.00 59.00 3.31 .26 6.97 71.30 26.50 62.83 1.06 
23. 
Bula Kumar 851332 39.00 2.15 12.50 1.00 80.90 12.05 .29 8.08 179.70 97.30 45.85 2.03 
24. 
Subash 945209 28.00 1.20 13.22 1.00 62.70 2.43 .29 7.83 33.60 12.10 63.99 1.44 
25. 
Palani 757166 34.00 3.26 19.52 1.00 71.60 11.69 .33 6.61 61.20 24.60 59.80 1.25 
26. 
Shenbagam 854585 30.00 1.63 15.67 1.00 53.30 4.15 .35 5.60 65.90 29.60 55.08 1.30 
27. Mathiur 
Rahman 854138 46.00 2.59 18.11 1.00 69.60 10.01 .25 7.50 121.60 47.80 60.69 1.83 
28. 
unnamalai 485997 27.00 1.60 12.50 1.00 66.60 9.46 .22 6.26 92.00 39.20 57.39 1.06 
29. 
Parimala 971158 34.00 2.29 15.47 1.00 50.30 14.12 .16 5.01 87.70 37.90 56.78 1.39 
30. 
Prabha 057218 44.00 2.00 17.24 1.00 47.90 7.96 .30 7.07 50.20 21.20 57.77 1.40 
31. 
Adi Narayan 855044 42.00 3.84 18.20 1.00 79.00 3.27 .27 6.04 112.80 83.10 26.33 1.21 
32. 
Govindamma 291495 38.30 3.21 18.77 1.00 61.00 4.91 .27 7.78 98.00 41.00 58.16 1.40 
33. 
Tamilarasi 118763 42.00 3.17 18.87 1.00 83.40 1.96 .21 6.13 88.60 38.00 57.11 2.17 
34. 
Sudhir 814510 39.00 7.12 33.02 2.00 89.00 15.65 .63 7.27 113.00 51.00 54.87 2.03 
35. 
Dhanabackiam 647567 52.80 7.40 39.36 2.00 93.20 15.55 .68 6.28 99.80 41.00 58.92 2.27 
36. 
Lakshmi 806089 23.80 7.15 29.42 2.00 79.00 21.45 .46 8.04 112.80 47.40 57.98 1.74 
37. 
Selvakumar 714070 39.00 7.10 39.66 2.00 95.00 12.05 .67 9.00 207.00 78.60 62.03 1.39 
38. 
Vijayakanth 809117 25.00 5.34 37.87 2.00 68.00 11.27 .51 8.20 224.40 92.40 58.82 1.41 
39. 
Lalitha 367403 49.00 8.03 39.56 2.00 91.00 31.10 .66 7.40 165.00 127.00 23.03 1.56 
40. 
Neelammal 797740 98.10 6.50 35.91 2.00 70.00 20.19 .68 5.80 41.30 18.90 54.24 1.90 
41. 
Mamata Mondal 020388 56.00 5.60 39.44 2.00 71.00 10.84 .51 6.68 93.00 38.00 59.14 1.21 
42. 
Shenbagavalli 880655 23.00 5.39 38.97 2.00 60.00 8.85 .51 6.61 99.00 41.00 58.59 1.70 
43. 
Ponnuswamy 790998 25.00 6.10 37.20 2.00 51.00 33.85 .51 6.30 120.50 72.10 40.17 1.40 
44. 
Karumbathi 699238 54.10 6.58 36.56 2.00 91.00 15.34 .52 7.30 88.00 32.00 63.64 1.21 
45. 
Udayakumar P 394476 47.00 8.07 38.25 2.00 70.00 15.85 .62 6.87 296.60 107.00 63.92 2.03 
46. 
Rani V 782418 41.00 5.60 29.79 2.00 46.00 10.60 .52 6.80 87.50 33.20 62.06 1.40 
47. 
Rajeswari 106439 91.00 7.10 39.93 2.00 106.00 12.70 .39 6.35 105.40 42.50 59.68 1.52 
48. 
Shova Sinha 936278 43.00 5.71 28.96 2.00 70.00 17.20 .56 5.95 77.70 34.20 55.98 1.46 
49. 
Selva Kumari 180539 66.00 7.08 39.78 2.00 93.00 12.89 .65 8.02 96.30 42.50 55.87 1.66 
50. 
Sivagami 133394 45.00 7.86 39.52 2.00 90.00 10.77 .57 5.50 95.00 33.00 65.26 1.50 
51. 
Saroj Yadav 833349 48.00 5.40 20.69 2.00 88.00 15.17 .55 5.97 101.90 42.50 58.29 1.81 
52. 
Jebamani 691869 51.00 6.36 37.86 2.00 75.00 10.00 .55 6.64 73.40 29.60 59.67 1.32 
53. 
Malar 188131 28.90 7.46 38.26 2.00 61.00 10.94 .58 6.01 94.90 41.70 56.06 1.17 
54. 
Selvam 122287 28.00 7.61 34.73 2.00 84.00 29.91 .61 8.01 175.90 115.50 34.34 1.67 
55. 
Jaikishan 802242 64.00 7.75 38.94 2.00 65.00 8.95 .61 7.00 56.30 22.50 60.04 2.10 
56. 
Kannammal 987375 24.00 5.86 26.76 2.00 84.00 16.65 .51 7.76 62.00 27.00 56.45 1.56 
57. 
Rose 254826 40.00 5.26 25.17 2.00 89.00 15.88 .53 6.05 113.90 50.50 55.66 1.36 
58. 
Rizwanullah 055663 50.00 9.00 34.09 2.00 60.70 19.14 .33 8.72 128.40 72.90 43.22 2.07 
59. 
Deviakiammal 853702 41.00 6.35 36.71 2.00 53.00 11.39 .56 6.31 75.10 32.80 56.32 2.12 
60. 
Ramkumar 858695 45.00 5.68 31.38 2.00 77.00 11.75 .53 6.40 324.70 160.70 50.51 1.45 
61. 
Rajeswari 991737 50.00 6.60 38.60 2.00 68.60 15.94 .51 6.09 57.20 25.60 55.24 1.32 
62. 
Raji 793469 71.00 8.10 38.21 2.00 90.80 16.55 .59 5.80 88.00 36.00 59.09 2.01 
63. 
Boobalan 838975 57.00 5.31 25.53 2.00 106.00 16.10 .56 7.20 83.10 35.00 57.88 2.04 
64. 
Prema 904545 25.00 18.49 48.94 3.00 110.00 66.87 1.06 8.60 96.00 41.50 56.77 2.74 
65. 
Shyamal Patra 803969 58.60 17.93 77.62 3.00 79.00 43.70 .75 7.75 152.00 110.00 27.63 2.40 
66. 
Vamathi 386556 55.70 20.28 86.30 3.00 141.00 42.93 .81 7.40 62.00 24.40 60.65 1.86 
67. 
Nila Khatun 812113 49.00 12.01 62.42 3.00 96.00 45.09 .85 6.73 90.50 39.90 55.91 2.10 
68. 
Deepti 814183 104.00 19.90 62.58 3.00 112.00 47.69 .11 6.98 43.20 17.90 58.56 2.25 
69. 
Govindaraj 573966 61.00 21.87 58.63 3.00 95.00 40.59 .90 7.60 202.00 86.00 57.43 1.80 
70. 
Veena Devi 812433 51.00 12.78 60.03 3.00 118.00 40.09 .97 4.90 94.40 40.30 57.31 2.30 
71. 
Ananda Paul 953948 47.20 11.50 46.79 3.00 96.00 43.64 .71 5.60 39.10 16.00 59.08 2.62 
72. 
Uthirakumar 773446 25.00 21.80 73.90 3.00 90.00 46.72 1.10 7.90 61.20 27.00 55.88 1.90 
73. 
Selvi 806969 83.20 13.82 50.07 3.00 101.00 40.10 .82 6.50 54.10 23.00 57.49 1.17 
74. 
Simson Mochar 795883 47.10 13.20 57.64 3.00 62.00 41.73 .91 7.76 242.00 180.00 25.62 2.70 
75. 
Harlin Rongha 770812 83.50 19.42 55.49 3.00 130.00 41.50 .12 7.88 74.20 32.20 56.60 2.62 
76. 
Kalpana 815920 127.00 14.20 73.20 3.00 129.00 41.44 .83 6.65 47.40 21.40 54.85 1.60 
77. 
Kamatchi 586712 26.85 12.82 45.51 3.00 110.00 46.41 .86 7.32 73.00 29.00 60.27 1.90 
78. 
Anowar Bibi 789661 60.00 15.30 63.33 3.00 130.00 44.19 .71 6.70 67.10 29.60 55.89 1.90 
79. 
Stella 601286 54.60 12.40 67.76 3.00 124.00 53.35 .98 6.80 74.20 29.00 60.92 1.90 
80. 
Ramamurthy 423256 62.20 16.53 64.57 3.00 103.00 48.09 .84 7.70 111.00 62.00 44.14 1.72 
81. Samsuddin 
Ansari 822130 47.80 12.63 65.78 3.00 114.00 45.30 .74 7.29 104.40 62.00 40.61 1.77 
82. 
Sasipriya 824669 83.00 26.30 75.36 3.00 102.00 40.76 .71 7.80 50.90 18.10 64.44 2.46 
83. 
Mamata Layek 772526 24.60 19.84 66.24 3.00 134.00 63.21 .98 7.82 46.40 18.30 60.56 2.60 
84. 
Palani 936065 45.00 21.94 45.91 3.00 64.00 52.41 .82 7.90 118.80 56.60 52.36 1.70 
85. 
Rani A 921834 27.00 25.27 65.62 3.00 144.00 76.15 1.00 7.34 83.10 32.60 60.77 3.00 
86. 
Sarada Devi 356600 33.75 25.85 76.25 3.00 102.00 41.65 .82 5.96 116.10 51.20 55.90 1.06 
87. 
Kapuri Devi 651668 40.50 16.75 68.37 3.00 100.00 56.08 .96 7.97 128.40 54.10 57.87 1.56 
88. 
Rani 836152 35.00 17.89 70.21 3.00 117.00 41.98 .80 7.78 118.80 79.00 33.50 1.99 
89. 
Arup Middya 219451 52.00 12.26 60.04 3.00 101.00 40.58 .78 7.19 246.50 162.00 34.28 2.03 
90. 
Janaki 329307 42.40 22.13 73.47 3.00 118.00 49.16 .91 7.08 79.80 32.50 59.27 1.65 
91. 
Tapan Dutta 837082 71.00 10.40 61.54 3.00 103.00 40.42 .76 7.20 65.50 25.80 60.61 2.04 
92. 
Jegan 925961 85.00 18.30 42.46 3.00 86.00 40.32 .76 7.30 66.10 28.30 57.19 2.13 
93. 
Nagarani K 803520 60.00 15.20 65.80 3.00 93.00 42.22 .70 7.16 89.40 36.70 58.95 2.68 
94. 
Usha 453241 57.00 13.90 43.99 3.00 96.00 43.45 .79 5.89 67.10 32.30 51.86 2.16 
95. 
Mani 054550 41.00 24.03 75.19 3.00 146.00 53.87 .88 5.91 72.10 28.50 60.47 2.90 
96. 
Jegadeesan 147654 51.90 18.42 88.60 3.00 136.00 50.58 .97 7.31 104.90 39.40 62.44 2.27 
97. 
Navamani 664841 74.00 11.00 48.03 3.00 52.00 40.10 .60 4.31 70.00 29.60 57.71 2.27 
98. 
Rajakumari 807061 131.00 11.50 78.34 3.00 109.00 46.59 .72 5.50 35.00 12.70 63.71 1.30 
99. 
Poongavanam 629747 86.00 27.70 48.94 3.00 131.00 40.79 .82 5.98 55.50 23.10 58.38 2.08 
100.
Md Yacob 466714 52.90 10.36 59.54 3.00 72.00 44.03 .70 7.10 115.50 48.80 57.75 2.25 
101.
Nirmala Maji 711006 23.80 21.30 46.58 3.00 99.00 49.50 .99 7.42 97.30 41.00 57.86 2.30 
102.
Pushpa Bala 037380 60.00 13.20 51.36 3.00 83.30 47.05 .72 8.30 96.80 46.80 51.65 2.12 
103.
Kishun Saw 854086 87.00 27.00 83.85 3.00 125.00 44.82 .82 5.93 65.50 26.50 59.54 2.03 
104.
Roshin Bauri 851557 71.00 15.20 61.79 3.00 101.00 42.36 .74 5.02 84.20 35.20 58.19 2.22 
105. Sakthivelmuru
gan 805006 69.00 13.10 53.69 3.00 108.00 40.92 .87 6.36 198.00 69.20 65.05 2.49 
106.
Shahabaz Alam 818185 96.30 14.82 64.86 3.00 84.00 40.21 .90 5.96 62.70 25.80 58.85 1.50 
107.
Devaki 428989 130.00 23.20 92.43 3.00 114.00 40.76 .88 6.83 87.70 37.90 56.78 1.79 
108.
Swapan Pal 726332 29.00 18.10 41.71 3.00 63.00 55.30 .86 4.88 48.50 20.60 57.53 2.64 
109.
Subramani K 423622 46.50 24.60 76.64 3.00 94.00 43.95 .96 7.29 136.00 77.00 43.38 3.02 
110.


























Sangeetha 647745 1.00 3.00 48.00 2.00 1.54 1.81 1.73 5.05 95.00 0 0 0 0 0 
2. 
Nazeera 267142 1.00 3.00 83.00 2.00 2.16 1.92 2.00 5.49 80.00 0 1 0 0 0 
3. 
Krishnakumar 818989 1.00 3.00 54.00 1.00 1.20 2.04 2.08 7.05 130.00 0 0 0 0 0 
4. 
Sarath Kumar 190237 1.00 3.00 24.00 1.00 1.78 1.83 1.91 4.53 89.00 0 0 0 0 0 
5. 
Zamruth 873457 1.00 3.00 31.00 2.00 1.15 1.75 1.92 4.79 95.00 0 0 0 0 0 
6. 
Malarkodi 472714 1.00 3.00 33.00 2.00 1.66 1.87 1.91 6.08 112.00 0 0 0 0 0 
7. 
Anbu Kumar 540013 1.00 3.00 43.90 2.00 1.61 1.91 2.03 15.10 86.00 0 0 0 0 0 
8. 
Rani P 421394 1.00 8.00 80.00 2.00 1.29 1.93 2.23 5.26 91.00 0 1 0 0 0 
9. 
Sulochana 447797 1.00 3.00 46.50 2.00 2.40 1.82 2.09 3.21 80.00 0 0 0 0 0 
10. 
Rogini 834512 1.00 3.00 42.00 2.00 1.50 1.96 2.33 6.99 52.00 0 0 0 0 0 
11. 
Senthil S 817686 1.00 3.00 33.67 2.00 1.49 1.92 1.98 3.57 90.00 0 0 0 0 0 
12. 
Valli 829150 1.00 3.00 23.00 2.00 1.32 1.92 1.96 4.91 68.00 0 0 0 0 0 
13. 
Nurul Hoda 789507 .00 8.00 74.00 2.00 1.74 2.05 2.11 8.11 9.00 0 0 0 0 0 
14. 
Kumari Bai 718782 1.00 3.00 51.00 2.00 1.57 1.73 1.93 4.63 82.00 0 0 0 0 0 
15. 
Shamim Akhtar 801553 1.00 3.00 30.00 1.00 1.53 1.89 1.90 6.51 63.00 0 0 0 0 0 
16. 
Kothandan M 201397 1.00 3.00 33.00 2.00 1.24 1.95 1.90 23.02 73.00 0 0 0 0 0 
17. 
Narendranath 811291 .00 8.00 34.00 2.00 1.69 1.93 1.99 4.91 96.00 0 1 0 0 0 
18. 
Vijaya 097264 .00 8.00 59.00 2.00 2.43 1.93 1.96 4.47 96.00 0 0 0 0 0 
19. 
Shantha 507139 1.00 3.00 30.00 2.00 1.39 1.85 1.92 6.15 76.00 0 0 0 0 0 
20. 
Govindammal 589740 1.00 3.00 29.00 2.00 1.72 2.06 2.11 7.44 72.00 0 0 0 0 0 
21. 
Arun Kumar 840116 1.00 3.00 30.00 1.00 1.93 1.73 1.66 5.11 81.00 0 0 0 0 0 
22. 
ShantiRanjan 839059 1.00 3.00 41.00 2.00 1.14 1.90 1.79 3.80 83.00 0 0 0 0 0 
23. 
Bula Kumar 851332 1.00 8.00 47.00 2.00 1.23 1.93 1.86 12.04 101.00 0 1 0 0 0 
24. 
Subash 945209 1.00 3.00 31.00 2.00 1.37 1.99 1.94 1.55 83.00 0 0 0 0 0 
25. 
Palani 757166 1.00 3.00 37.00 2.00 1.46 1.99 2.10 3.72 90.00 0 0 0 0 0 
26. 
Shenbagam 854585 1.00 3.00 33.00 2.00 1.87 1.58 1.58 5.29 89.00 0 0 0 0 0 
27. Mathiur 
Rahman 854138 .00 8.00 54.00 2.00 1.58 2.03 1.98 6.37 76.00 0 0 0 0 0 
28. 
unnamalai 485997 1.00 3.00 30.00 2.00 1.75 1.90 1.93 6.26 62.00 0 0 0 0 0 
29. 
Parimala 971158 1.00 3.00 37.00 2.00 1.17 1.97 1.95 7.56 90.00 0 0 0 0 0 
30. 
Prabha 057218 1.00 3.00 47.00 2.00 1.30 1.92 1.98 3.00 73.00 0 0 0 0 0 
31. 
Adi Narayan 855044 1.00 3.00 45.00 2.00 1.73 1.83 2.23 13.76 113.00 0 0 0 0 0 
32. 
Govindamma 291495 1.00 3.00 41.30 2.00 1.49 1.94 1.98 5.27 69.00 0 0 0 0 0 
33. 
Tamilarasi 118763 1.00 8.00 50.00 2.00 1.91 1.90 1.90 6.20 71.00 0 0 0 0 0 
34. 
Sudhir 814510 .00 8.00 47.00 2.00 1.50 2.10 2.04 7.02 57.00 1 0 0 0 0 
35. 
Dhanabackiam 647567 .00 15.00 67.80 2.00 2.50 2.11 2.03 6.53 105.00 1 1 0 0 1 
36. 
Lakshmi 806089 .00 8.00 31.80 2.00 1.41 1.94 2.02 5.90 87.00 0 0 0 0 0 
37. 
Selvakumar 714070 1.00 3.00 42.00 2.00 1.41 2.25 2.48 8.73 71.00 1 0 0 0 0 
38. 
Vijayakanth 809117 1.00 3.00 28.00 2.00 1.22 2.05 2.02 11.27 80.00 0 1 0 0 0 
39. 
Lalitha 367403 .00 8.00 57.00 2.00 1.92 2.17 2.33 17.16 106.00 1 1 0 1 0 
40. 
Neelammal 797740 .00 8.00 106.10 2.00 2.78 1.97 1.95 3.26 90.00 0 0 0 0 0 
41. 
Mamata Mondal 020388 1.00 3.00 59.00 2.00 1.95 2.07 2.10 5.69 96.00 0 0 0 0 0 
42. 
Shenbagavalli 880655 1.00 3.00 26.00 2.00 2.20 2.13 2.04 6.20 92.00 0 0 0 0 0 
43. 
Ponnuswamy 790998 1.00 3.00 28.00 2.00 1.97 2.10 2.12 11.44 96.00 0 0 0 0 0 
44. 
Karumbathi 699238 1.00 3.00 57.10 2.00 2.23 2.16 1.93 4.38 70.00 0 0 0 0 0 
45. 
Udayakumar P 394476 .00 8.00 55.00 2.00 2.01 2.21 2.40 15.57 115.00 0 0 0 0 0 
46. 
Rani V 782418 1.00 3.00 44.00 2.00 1.51 1.99 1.98 4.88 78.00 0 0 0 0 0 
47. 
Rajeswari 106439 1.00 3.00 94.00 2.00 1.86 2.00 1.92 6.69 88.00 0 1 0 0 0 
48. 
Shova Sinha 936278 1.00 3.00 46.00 2.00 1.25 2.05 2.05 5.75 106.00 0 0 0 0 0 
49. 
Selva Kumari 180539 .00 8.00 74.00 2.00 1.78 2.02 2.09 5.30 96.00 0 0 0 0 0 
50. 
Sivagami 133394 1.00 3.00 48.00 2.00 1.33 1.98 1.99 6.00 106.00 0 1 0 0 0 
51. 
Saroj Yadav 833349 .00 8.00 55.00 2.00 1.43 2.11 2.39 7.12 63.00 0 0 0 0 0 
52. 
Jebamani 691869 1.00 3.00 54.00 2.00 1.50 1.97 2.11 4.46 67.00 0 0 0 0 0 
53. 
Malar 188131 1.00 3.00 31.90 2.00 1.53 2.27 2.42 6.94 78.00 0 0 0 0 0 
54. 
Selvam 122287 .00 8.00 36.00 2.00 2.43 2.23 2.28 14.42 108.00 0 0 0 0 0 
55. 
Jaikishan 802242 .00 8.00 72.00 2.00 1.66 2.17 1.91 3.21 101.00 0 0 0 0 0 
56. 
Kannammal 987375 .00 8.00 32.00 2.00 1.41 1.93 1.98 3.48 88.00 0 0 0 0 0 
57. 
Rose 254826 1.00 3.00 43.00 2.00 2.04 2.03 1.99 8.35 129.00 0 0 0 0 0 
58. 
Rizwanullah 055663 1.00 8.00 58.00 1.00 1.96 1.96 1.96 8.36 106.00 0 0 0 0 0 
59. 
Deviakiammal 853702 1.00 8.00 49.00 2.00 1.73 2.00 1.96 5.20 108.00 0 0 0 0 0 
60. 
Ramkumar 858695 1.00 3.00 48.00 2.00 1.99 2.20 2.49 25.11 98.00 0 0 0 0 0 
61. 
Rajeswari 991737 1.00 3.00 53.00 2.00 1.37 1.92 1.99 4.20 77.00 0 0 0 0 0 
62. 
Raji 793469 .00 8.00 79.00 2.00 1.54 2.20 2.21 6.21 110.00 0 0 0 0 0 
63. 
Boobalan 838975 .00 8.00 65.00 2.00 2.48 2.20 2.16 4.86 101.00 0 0 0 0 0 
64. 
Prema 904545 .00 15.00 40.00 2.00 2.19 2.17 2.09 4.83 70.00 1 1 0 0 0 
65. 
Shyamal Patra 803969 .00 15.00 73.60 2.00 2.86 2.19 2.26 14.19 100.00 1 0 0 0 0 
66. 
Vamathi 386556 .00 8.00 63.70 2.00 2.00 2.21 2.52 3.30 116.00 1 1 0 0 1 
67. 
Nila Khatun 812113 .00 8.00 57.00 2.00 2.14 2.21 2.50 5.93 127.00 0 0 0 0 0 
68. 
Deepti 814183 .00 15.00 119.00 3.00 2.90 2.11 2.11 2.56 72.00 1 1 0 1 0 
69. 
Govindaraj 573966 1.00 3.00 64.00 3.00 1.52 2.30 2.27 11.32 89.00 1 1 0 0 1 
70. 
Veena Devi 812433 .00 15.00 66.00 2.00 1.71 2.59 2.78 8.22 63.00 1 1 0 0 1 
71. 
Ananda Paul 953948 .00 15.00 62.20 2.00 3.17 2.32 2.27 2.86 70.00 1 0 0 0 1 
72. 
Uthirakumar 773446 .00 8.00 33.00 2.00 2.19 2.29 2.33 3.42 80.00 1 1 0 0 0 
73. 
Selvi 806969 1.00 3.00 86.20 3.00 2.89 2.31 2.25 3.54 96.00 1 0 0 0 0 
74. 
Simson Mochar 795883 .00 15.00 62.10 2.00 2.58 2.32 2.36 23.20 98.00 1 1 0 0 0 
75. 
Harlin Rongha 770812 .00 15.00 98.50 2.00 3.10 2.10 2.08 4.09 110.00 1 1 0 0 1 
76. 
Kalpana 815920 1.00 3.00 130.00 2.00 2.83 2.09 2.10 3.22 95.00 0 1 1 0 0 
77. 
Kamatchi 586712 .00 8.00 34.85 2.00 2.25 2.21 2.28 3.96 112.00 0 0 1 0 0 
78. 
Anowar Bibi 789661 1.00 3.00 63.00 2.00 3.57 2.26 2.12 4.42 73.00 1 1 0 0 1 
79. 
Stella 601286 .00 8.00 62.60 2.00 2.11 2.25 2.65 4.26 134.00 1 1 0 0 1 
80. 
Ramamurthy 423256 1.00 3.00 65.20 2.00 2.27 2.14 2.07 8.05 81.00 1 1 0 0 0 
81. Samsuddin 
Ansari 822130 .00 8.00 55.80 2.00 1.93 2.31 2.05 8.50 60.00 1 1 0 0 0 
82. 
Sasipriya 824669 .00 15.00 98.00 3.00 3.61 2.12 2.11 2.32 86.00 1 1 0 0 1 
83. 
Mamata Layek 772526 .00 15.00 39.60 2.00 2.18 2.18 2.22 2.34 93.00 0 1 0 0 0 
84. 
Palani 936065 1.00 3.00 48.00 2.00 1.72 2.64 2.45 7.16 77.00 0 1 0 0 0 
85. 
Rani A 921834 .00 15.00 42.00 2.00 3.48 2.62 2.38 4.44 70.00 1 1 1 0 1 
86. 
Sarada Devi 356600 1.00 3.00 36.75 2.00 1.79 2.48 2.38 8.59 103.00 1 1 0 0 0 
87. 
Kapuri Devi 651668 .00 8.00 48.50 2.00 1.69 2.78 2.81 6.79 88.00 1 1 0 1 0 
88. 
Rani 836152 1.00 3.00 38.00 2.00 1.63 2.24 2.31 10.15 93.00 1 1 0 1 0 
89. 
Arup Middya 219451 1.00 3.00 55.00 2.00 2.83 2.21 2.19 22.53 81.00 0 1 0 0 0 
90. 
Janaki 329307 1.00 3.00 45.40 2.00 2.08 2.22 2.34 4.59 75.00 1 1 1 1 1 
91. 
Tapan Dutta 837082 .00 8.00 79.00 2.00 2.61 2.18 2.15 3.58 119.00 1 0 1 1 1 
92. 
Jegan 925961 .00 15.00 100.00 2.00 6.04 2.16 2.28 3.88 63.00 0 1 0 0 1 
93. 
Nagarani K 803520 .00 15.00 75.00 2.00 1.68 2.36 2.33 5.13 104.00 1 1 0 0 0 
94. 
Usha 453241 1.00 8.00 65.00 2.00 1.76 2.20 2.20 5.48 64.00 0 1 0 0 1 
95. 
Mani 054550 .00 15.00 56.00 2.00 2.61 2.25 2.15 4.82 88.00 1 0 0 0 1 
96. 
Jegadeesan 147654 .00 15.00 66.90 2.00 2.14 2.12 2.13 5.39 94.00 1 1 0 0 1 
97. 
Navamani 664841 .00 15.00 89.00 2.00 2.03 2.12 2.08 6.87 80.00 1 0 0 0 0 
98. 
Rajakumari 807061 1.00 3.00 134.00 2.00 2.91 2.03 1.98 2.31 96.00 1 0 0 0 0 
99. 
Poongavanam 629747 1.00 3.00 89.00 2.00 1.88 2.25 2.34 3.86 87.00 1 1 0 0 1 
100.
Md Yacob 466714 1.00 8.00 60.90 2.00 1.70 2.31 2.25 6.87 86.00 0 1 0 0 0 
101.
Nirmala Maji 711006 1.00 8.00 31.80 2.00 2.68 2.20 2.04 5.53 85.00 1 1 0 0 0 
102.
Pushpa Bala 037380 .00 15.00 75.00 2.00 1.97 2.63 3.33 5.64 66.00 1 1 0 0 0 
103.
Kishun Saw 854086 .00 8.00 95.00 2.00 4.11 2.08 2.08 4.47 60.00 1 1 0 0 1 
104.
Roshin Bauri 851557 .00 15.00 86.00 2.00 3.40 2.08 2.05 7.01 105.00 0 1 0 0 0 
105. Sakthivelmuru
gan 805006 .00 15.00 84.00 2.00 2.30 3.05 2.90 10.88 108.00 0 0 0 0 0 
106.
Shahabaz Alam 818185 1.00 3.00 99.30 2.00 4.40 2.31 2.34 4.33 98.00 1 1 0 0 0 
107.
Devaki 428989 .00 8.00 138.00 2.00 2.11 2.28 2.27 5.55 105.00 1 1 0 0 0 
108.
Swapan Pal 726332 .00 15.00 44.00 2.00 2.39 2.14 2.03 4.22 89.00 1 1 0 0 0 
109.
Subramani K 423622 .00 15.00 61.50 2.00 2.31 2.19 2.12 10.56 123.00 1 1 0 0 0 
110.

























































Sangeetha 647745 0 1 1 1 0 0 0 1 14.30 26.20 15.40 3.00 2.70 6.50 8.96 1.72 2.09 
2. 
Nazeera 267142 0 1 1 0 0 0 0 4 18.50 28.50 19.40 3.20 3.00 8.18 10.20 2.03 2.30 
3. 
Krishnakumar 818989 0 1 0 0 1 0 0 1 19.00 24.00 12.50 2.70 2.40 5.10 8.10 1.76 2.37 
4. 
Sarath Kumar 190237 0 1 1 1 1 0 0 1 21.60 24.00 17.80 2.70 2.40 4.80 7.70 1.49 1.69 
5. 
Zamruth 873457 0 0 0 1 0 0 1 1 19.10 26.40 18.40 3.50 3.10 8.43 10.20 1.64 2.14 
6. 
Malarkodi 472714 0 1 1 0 0 0 1 1 10.30 12.30 12.50 3.30 2.90 7.70 9.75 1.66 1.97 
7. 
Anbu Kumar 540013 0 1 1 1 0 0 0 2 21.20 23.20 22.40 2.80 2.50 5.70 8.40 1.74 1.97 
8. 
Rani P 421394 1 1 1 0 1 0 1 1 5.80 12.40 7.50 3.00 2.70 6.00 8.70 1.40 1.78 
9. 
Sulochana 447797 0 1 1 0 0 0 0 4 20.10 22.50 21.60 3.00 2.60 6.20 8.90 1.98 2.28 
10. 
Rogini 834512 0 1 1 0 0 0 0 1 11.70 18.40 15.30 3.30 3.00 7.92 9.90 2.03 2.55 
11. 
Senthil S 817686 0 1 0 1 0 0 0 1 8.20 16.30 13.80 3.20 2.90 7.42 9.60 1.66 2.06 
12. 
Valli 829150 0 0 0 0 0 0 0 1 10.70 14.70 14.30 2.70 2.60 5.62 8.40 1.42 1.64 
13. 
Nurul Hoda 789507 0 1 0 0 0 0 1 6 18.40 24.60 23.20 3.20 3.00 7.90 9.80 1.31 1.53 
14. 
Kumari Bai 718782 0 1 1 0 0 0 0 1 11.30 14.30 13.90 3.20 2.90 7.50 9.60 1.65 2.10 
15. 
Shamim Akhtar 801553 0 0 0 0 0 0 0 1 15.80 16.00 15.80 3.10 2.70 6.80 9.30 1.18 1.48 
16. 
Kothandan M 201397 0 1 1 1 0 1 0 2 9.40 10.60 10.40 2.80 2.60 5.62 8.50 1.49 1.69 
17. 
Narendranath 811291 0 0 0 0 0 0 0 7 21.00 23.00 22.70 3.50 3.20 9.75 11.20 2.10 2.33 
18. 
Vijaya 097264 0 1 0 1 0 0 0 1 7.20 12.10 10.10 3.20 2.90 7.40 9.60 2.10 2.36 
19. 
Shantha 507139 0 0 0 0 0 0 0 1 10.50 11.90 11.40 3.10 2.80 7.00 9.30 1.77 2.00 
20. 
Govindammal 589740 0 1 1 0 0 1 0 1 7.40 13.40 13.00 3.20 2.80 7.20 9.50 1.65 1.85 
21. 
Arun Kumar 840116 0 1 0 1 0 0 0 1 12.20 16.20 19.80 3.30 3.00 7.92 9.90 1.67 2.04 
22. 
ShantiRanjan 839059 0 1 1 1 1 0 0 1 24.80 27.30 23.40 3.00 2.70 6.50 9.00 1.51 1.78 
23. 
Bula Kumar 851332 0 1 0 0 1 0 0 1 12.10 15.00 11.20 2.95 2.60 6.10 8.70 1.92 2.36 
24. 
Subash 945209 0 1 1 0 0 0 0 2 7.00 8.00 7.60 3.40 3.10 8.45 10.30 2.08 2.46 
25. 
Palani 757166 0 1 0 0 1 0 0 6 13.60 17.10 16.00 3.30 3.00 8.10 9.90 2.35 2.68 
26. 
Shenbagam 854585 0 0 0 0 0 0 0 1 15.00 18.00 16.00 3.00 2.80 6.72 9.20 1.80 2.00 
27. Mathiur 
Rahman 854138 0 1 1 0 0 0 1 1 15.00 26.00 20.30 3.40 3.10 8.43 10.30 1.43 1.86 
28. 
unnamalai 485997 0 0 0 1 0 0 0 1 16.00 23.00 20.50 2.90 2.60 6.10 8.70 1.36 1.62 
29. 
Parimala 971158 0 1 0 1 0 0 0 1 15.00 19.00 17.00 3.30 2.90 7.70 10.00 1.62 1.78 
30. 
Prabha 057218 0 1 1 0 0 0 0 1 13.10 25.00 22.40 2.80 2.40 5.40 8.30 1.46 1.84 
31. 
Adi Narayan 855044 0 1 1 1 1 0 0 2 14.10 22.10 19.00 3.40 3.10 8.40 10.20 1.99 2.29 
32. 
Govindamma 291495 0 1 0 1 0 0 0 1 25.10 32.50 19.20 3.50 3.30 9.10 10.90 1.54 1.72 
33. 
Tamilarasi 118763 0 1 0 1 0 0 0 1 19.40 28.10 24.90 2.90 2.70 6.30 9.20 1.48 1.68 
34. 
Sudhir 814510 0 0 0 0 0 0 1 1 19.30 25.60 22.30 3.10 3.60 8.65 10.40 1.80 2.34 
35. 
Dhanabackiam 647567 1 1 1 0 0 0 1 1 13.10 22.30 16.60 2.90 3.20 7.50 9.60 1.84 2.17 
36. 
Lakshmi 806089 0 1 1 0 0 0 1 1 23.00 23.00 25.90 2.90 3.20 7.20 9.50 2.17 2.56 
37. 
Selvakumar 714070 1 1 0 1 0 1 0 1 16.00 27.00 22.80 3.00 3.20 7.45 9.60 1.75 1.97 
38. 
Vijayakanth 809117 1 1 1 0 0 0 0 1 26.00 27.80 21.20 3.10 3.40 8.45 10.30 1.81 2.06 
39. 
Lalitha 367403 1 1 1 1 1 0 0 2 23.70 30.70 30.90 3.20 3.50 9.10 11.00 2.17 2.53 
40. 
Neelammal 797740 1 1 1 0 0 0 0 4 32.00 44.70 42.00 3.25 3.50 8.70 10.40 2.14 2.60 
41. 
Mamata Mondal 020388 0 1 1 0 0 0 0 1 18.00 26.10 22.10 2.70 2.90 6.10 8.70 1.85 2.10 
42. 
Shenbagavalli 880655 0 0 1 0 1 0 0 6 14.80 21.30 17.60 3.10 3.30 7.80 9.80 1.89 2.17 
43. 
Ponnuswamy 790998 0 1 0 0 1 0 1 3 19.40 22.20 16.70 3.20 3.40 8.15 10.10 1.95 2.21 
44. 
Karumbathi 699238 0 1 1 1 0 0 0 1 29.40 36.90 30.80 3.50 3.60 9.50 10.90 1.76 2.08 
45. 
Udayakumar P 394476 1 1 1 0 1 0 1 1 33.60 35.60 31.60 3.20 3.50 8.95 10.60 1.57 2.03 
46. 
Rani V 782418 0 1 1 0 0 0 0 1 20.40 27.80 20.40 3.30 3.60 9.50 10.90 2.38 2.76 
47. 
Rajeswari 106439 1 1 1 1 1 0 0 1 19.30 22.30 22.30 3.10 3.30 8.20 10.20 2.05 2.43 
48. 
Shova Sinha 936278 0 1 1 0 0 0 1 1 21.40 22.30 22.00 3.10 3.30 8.00 9.70 1.68 2.00 
49. 
Selva Kumari 180539 0 1 1 1 0 0 0 1 28.00 29.30 19.50 3.50 3.70 10.10 11.20 2.04 2.33 
50. 
Sivagami 133394 1 1 1 0 0 0 1 1 21.20 23.10 22.00 3.00 3.20 7.40 9.60 2.14 2.54 
51. 
Saroj Yadav 833349 1 1 1 1 0 0 0 1 22.20 24.70 21.70 3.65 3.80 10.30 11.30 2.06 2.26 
52. 
Jebamani 691869 0 1 0 0 0 0 0 1 23.00 28.00 23.00 3.40 3.60 9.80 11.00 2.11 2.51 
53. 
Malar 188131 0 1 1 1 0 0 0 1 16.50 20.50 20.30 3.40 3.60 9.80 11.10 1.74 2.24 
54. 
Selvam 122287 0 1 1 1 0 0 0 3 26.70 26.70 23.80 3.40 3.70 10.10 11.30 1.90 2.05 
55. 
Jaikishan 802242 1 1 0 0 0 0 1 1 15.10 21.00 21.20 3.00 3.20 7.20 9.60 1.72 2.00 
56. 
Kannammal 987375 0 0 1 0 0 0 1 1 24.20 24.40 24.60 3.25 3.60 8.95 10.60 1.55 1.85 
57. 
Rose 254826 0 0 0 0 0 0 0 1 17.00 27.00 19.20 3.40 3.50 9.52 10.90 1.94 2.32 
58. 
Rizwanullah 055663 0 1 0 1 0 0 0 2 15.00 21.00 19.10 3.40 3.60 9.22 10.70 1.71 1.92 
59. 
Deviakiammal 853702 1 1 1 0 0 0 1 1 11.10 16.50 10.80 3.30 3.50 9.24 10.70 2.20 2.67 
60. 
Ramkumar 858695 0 0 0 0 0 0 0 1 17.00 28.00 19.30 3.30 3.80 10.10 11.30 2.36 2.78 
61. 
Rajeswari 991737 0 1 0 1 0 0 0 1 18.00 22.00 20.90 2.90 3.10 7.19 9.60 1.79 2.15 
62. 
Raji 793469 0 1 1 0 0 0 0 1 18.00 25.00 23.60 2.70 2.90 6.60 9.10 1.76 2.06 
63. 
Boobalan 838975 0 1 0 1 1 0 0 1 14.00 28.40 28.20 3.40 3.60 9.80 11.20 1.91 2.18 
64. 
Prema 904545 1 1 1 0 0 0 1 1 37.50 43.70 31.20 3.80 4.00 11.85 12.10 2.40 2.94 
65. 
Shyamal Patra 803969 1 1 1 0 1 0 0 2 33.10 42.70 37.20 4.10 4.20 13.78 13.20 2.14 2.47 
66. 
Vamathi 386556 1 1 0 1 1 0 1 1 28.40 38.00 31.40 4.10 4.20 13.44 13.10 2.03 2.65 
67. 
Nila Khatun 812113 1 1 1 0 0 0 0 1 28.20 36.70 32.60 3.90 4.10 12.46 12.50 1.96 2.42 
68. 
Deepti 814183 1 1 1 0 0 0 0 1 25.30 32.90 27.60 3.60 3.70 10.10 11.20 2.31 2.81 
69. 
Govindaraj 573966 1 1 1 1 0 0 0 1 25.80 30.80 27.50 4.40 4.50 15.82 14.10 2.39 2.84 
70. 
Veena Devi 812433 1 1 1 0 0 0 1 1 23.50 35.10 37.80 4.00 4.20 12.43 12.40 2.68 3.24 
71. 
Ananda Paul 953948 0 0 0 0 0 0 0 7 22.70 35.00 33.60 4.20 4.30 14.10 13.20 2.51 2.93 
72. 
Uthirakumar 773446 1 1 0 1 0 0 0 8 28.10 36.60 31.20 4.20 4.30 14.45 13.40 2.10 2.46 
73. 
Selvi 806969 0 1 1 0 0 0 0 4 52.00 57.50 42.00 3.50 3.60 10.10 11.30 1.91 2.49 
74. 
Simson Mochar 795883 1 1 0 0 0 0 0 6 37.00 42.00 33.90 4.20 4.30 14.45 13.40 2.07 2.64 
75. 
Harlin Rongha 770812 1 1 1 0 0 0 1 1 29.40 46.30 32.20 4.40 4.60 16.20 14.20 2.22 2.58 
76. 
Kalpana 815920 1 1 0 1 0 0 0 1 35.50 46.00 40.40 3.50 3.60 10.10 11.10 2.37 3.01 
77. 
Kamatchi 586712 0 1 1 1 0 0 0 9 36.50 39.00 32.00 4.50 4.50 15.50 14.20 2.26 2.68 
78. 
Anowar Bibi 789661 1 1 1 0 0 0 0 1 35.00 45.00 33.50 4.10 4.20 13.70 13.20 2.61 3.00 
79. 
Stella 601286 1 1 1 0 0 0 0 1 41.00 45.90 42.00 3.65 3.80 11.00 11.80 2.46 3.10 
80. 
Ramamurthy 423256 0 1 1 1 1 0 0 2 31.40 48.30 40.50 4.10 4.30 14.00 13.60 2.13 2.57 
81. Samsuddin 
Ansari 822130 1 1 1 0 0 0 0 6 38.80 48.90 47.30 4.00 4.20 13.40 12.80 2.41 3.08 
82. 
Sasipriya 824669 1 1 1 0 0 0 1 4 31.00 38.00 29.00 3.95 4.20 13.10 13.00 2.59 2.96 
83. 
Mamata Layek 772526 0 1 1 0 0 0 0 1 27.00 35.50 28.80 4.40 4.50 15.10 14.00 2.90 3.12 
84. 
Palani 936065 0 1 1 0 1 0 1 1 29.80 31.20 30.20 5.05 5.20 20.40 16.10 2.64 3.13 
85. 
Rani A 921834 1 1 1 0 0 0 1 1 31.30 42.00 31.00 5.60 5.70 25.30 18.10 4.02 4.37 
86. 
Sarada Devi 356600 1 1 1 0 0 0 0 1 29.50 35.80 30.00 4.20 4.40 14.70 13.30 2.57 3.01 
87. 
Kapuri Devi 651668 1 1 1 0 0 0 1 1 24.20 33.80 26.00 4.65 4.70 15.00 14.20 3.31 3.78 
88. 
Rani 836152 1 1 1 1 1 0 0 2 36.10 45.10 39.80 4.20 4.40 14.10 13.60 2.09 2.51 
89. 
Arup Middya 219451 1 1 1 1 1 0 0 3 34.20 37.90 35.20 4.20 4.30 13.20 13.10 2.47 2.70 
90. 
Janaki 329307 1 1 1 0 0 0 1 1 34.00 36.90 39.00 3.65 3.80 11.20 12.30 2.52 2.73 
91. 
Tapan Dutta 837082 1 0 1 0 1 1 0 7 31.30 43.00 34.60 3.80 4.00 13.20 13.00 2.11 2.35 
92. 
Jegan 925961 1 1 1 0 0 0 1 4 39.00 42.60 40.10 4.40 4.50 15.30 14.40 2.54 2.84 
93. 
Nagarani K 803520 1 1 1 1 0 0 0 1 23.00 34.20 27.80 3.90 4.10 12.10 12.70 2.71 3.10 
94. 
Usha 453241 1 1 1 1 0 0 0 1 29.00 35.00 29.30 3.90 4.00 10.70 12.80 2.38 3.06 
95. 
Mani 054550 1 1 1 0 0 0 1 1 30.20 36.90 34.10 4.40 4.50 15.70 14.40 2.42 2.72 
96. 
Jegadeesan 147654 1 1 1 0 0 0 1 1 35.10 40.60 36.30 4.30 4.40 13.00 13.50 2.36 2.66 
97. 
Navamani 664841 0 1 1 0 0 0 0 4 29.00 36.00 32.10 3.70 3.80 11.20 13.40 2.44 2.90 
98. 
Rajakumari 807061 0 1 0 0 0 0 0 4 44.30 47.00 38.30 3.50 3.70 10.30 11.30 2.56 3.02 
99. 
Poongavanam 629747 1 1 1 0 0 0 1 1 27.00 30.00 28.20 4.20 4.40 14.00 14.10 2.88 3.22 
100.
Md Yacob 466714 1 0 0 0 0 0 0 1 28.40 41.90 33.90 3.90 4.10 12.20 13.20 2.05 2.37 
101.
Nirmala Maji 711006 1 1 1 0 0 0 0 1 44.40 54.80 43.90 4.75 4.80 16.40 15.20 3.28 3.67 
102.
Pushpa Bala 037380 1 0 0 0 0 0 0 1 27.20 40.30 20.20 4.10 4.30 13.40 13.40 3.00 3.53 
103.
Kishun Saw 854086 1 1 1 0 0 0 0 1 34.00 39.90 34.10 4.15 4.30 12.70 15.20 2.19 2.56 
104.
Roshin Bauri 851557 1 1 0 0 0 0 0 7 32.00 40.00 36.00 3.90 4.10 12.10 13.60 2.59 3.13 
105. Sakthivelmuru
gan 805006 0 1 1 0 1 0 1 1 34.40 35.80 35.20 4.30 4.50 15.50 14.40 2.90 3.26 
106.
Shahabaz Alam 818185 1 1 1 1 0 0 0 1 34.10 38.10 38.40 3.70 3.90 11.50 12.20 2.67 3.04 
107.
Devaki 428989 0 1 1 1 0 0 0 1 23.90 31.40 36.00 4.00 4.20 13.10 12.80 2.15 2.47 
108.
Swapan Pal 726332 1 1 0 0 0 0 0 6 29.20 31.80 31.60 4.50 4.60 16.50 14.70 2.55 2.80 
109.
Subramani K 423622 0 1 1 1 1 0 0 3 29.00 32.60 30.80 4.45 4.50 15.10 14.30 2.44 2.84 
110.








Name ID Age Sex Height Weight BSA Rhythm RVmid RVBasal 
RV 
long RVEDA RVESA RVFAC RVTei IVA TAPSE 
1. 
Idrish 839314 62 1 167 53 1.59 1.00 2.00 3.23 6.30 16.80 9.59 42.92 .47 7.19 2.42 
2. 
Bikram 854084 36 1 170 70 1.81 1.00 1.93 2.88 7.10 14.50 7.98 44.97 .53 4.87 2.22 
3. 
Pravas 846462 48 1 150 50 1.43 1.00 2.52 3.19 5.94 15.30 9.35 38.89 .50 3.59 2.31 
4. 
Damodaran 412671 54 1 160 48 1.48 1.00 2.54 3.24 5.99 13.90 7.77 44.10 .54 3.67 2.23 
5. 
shyamal 128811 55 1 160 60 1.62 1.00 2.21 2.91 6.83 11.90 8.60 27.73 .52 5.00 2.36 
6. 
Vijayalakshmi 847954 52 2 151 40 1.31 1.00 2.11 2.67 5.77 12.13 6.42 47.07 .51 3.70 2.19 
7. 
Asha singh 192234 54 2 150 57 1.51 1.00 1.91 2.55 6.22 11.80 6.23 47.20 .50 7.50 2.60 
8. 
Duli Rani 856200 47 2 152 50 1.45 1.00 2.31 2.81 5.89 13.00 8.26 36.46 .50 7.14 2.27 
9. 
Alice 460595 32 2 146 57 1.49 1.00 2.21 3.16 6.08 12.40 8.70 29.84 .51 6.00 2.06 
10.
Achama 038065 63 2 148 63 1.57 1.00 2.54 3.16 5.69 13.30 7.67 42.33 .46 3.44 2.29 
11.
Kamalakant 856699 65 1 155 60 1.59 1.00 2.18 3.37 5.60 13.80 7.30 47.10 .61 3.43 2.04 
12.
Gangammal 563848 60 2 154 55 1.52 1.00 1.92 2.41 6.28 14.10 7.50 46.81 .52 5.71 2.31 
13.
Takheyalyo 858833 52 2 147 43 1.32 1.00 2.38 3.06 6.54 13.70 7.99 41.68 .54 3.43 2.01 
14.
Ruckmani 849764 55 2 146 43 1.32 1.00 2.10 2.58 5.26 10.80 6.60 38.89 .47 3.81 2.09 
15.
Rajaul 794209 45 1 173 62 1.74 1.00 2.43 3.46 6.38 15.30 7.40 51.63 .52 4.00 2.06 
16.
Ratan Paul 798188 43 1 167 67 1.75 1.00 2.70 3.40 5.80 17.00 11.40 32.94 .52 2.89 2.12 
17.
Nitish Kumar 856546 22 1 169 65 1.75 1.00 2.65 3.60 5.90 19.20 10.10 47.40 .56 3.70 2.16 
18.
Basant Yadav 854074 53 1 173 60 1.72 1.00 2.20 3.20 6.10 15.40 9.10 40.91 .50 3.33 2.56 
19.
Piritosh 850648 60 1 179 67 1.84 1.00 2.40 2.90 6.10 10.40 7.40 28.85 .52 3.08 2.20 
20.
Pritilata 859942 19 2 158 52 1.51 1.00 2.30 3.10 6.10 13.10 8.00 38.93 .52 4.00 2.20 
21.














Idrish 839314 .15 7.47 94.40 34.70 63.24 1.10 1.52 1.97 1.99 4.65 88.00 2.90 
2.  
Bikram 854084 .18 7.07 101.90 41.30 59.47 2.08 1.12 1.86 1.86 5.84 88.00 3.30 
3.  
Pravas 846462 .13 6.82 72.10 29.60 58.95 1.02 1.57 1.94 1.87 4.34 86.00 3.10 
4.  
Damodaran 412671 .19 6.14 75.90 29.30 61.40 1.13 1.30 1.92 1.91 4.77 84.00 3.00 
5.  
shyamal 128811 .25 7.49 107.50 41.00 61.86 1.23 1.26 1.92 1.93 5.47 96.00 2.80 
6.  
Vijayalakshmi 847954 .24 6.84 85.80 35.00 59.21 1.36 1.11 1.88 1.92 5.12 98.00 2.70 
7.  
Asha singh 192234 .18 6.44 87.70 37.90 56.78 1.06 1.00 1.96 1.99 5.89 96.00 3.20 
8.  
Duli Rani 856200 .19 6.84 70.00 29.60 57.71 1.31 1.40 1.83 1.66 4.33 91.00 2.40 
9.  
Alice 460595 .17 6.89 87.70 36.40 58.49 1.50 1.43 1.86 1.74 5.28 84.00 3.00 
10.  
Achama 038065 .19 5.78 88.20 39.40 55.33 1.17 1.35 1.87 1.61 6.82 70.00 2.80 
11.  
Kamalakant 856699 .15 6.89 102.40 44.10 56.93 1.17 1.30 1.88 1.96 6.40 74.00 3.00 
12.  
Gangammal 563848 .24 7.74 72.10 31.40 56.45 1.48 1.19 2.15 1.94 4.06 88.00 3.00 
13.  
Takheyalyo 858833 .13 6.81 78.60 35.00 55.47 1.32 1.22 1.86 1.92 5.14 81.00 3.30 
14.  
Ruckmani 849764 .18 7.04 58.10 24.60 57.66 1.36 1.25 1.96 1.92 3.49 79.00 2.70 
15.  
Rajaul 794209 .16 7.20 102.40 44.10 56.93 1.31 1.16 1.91 1.95 6.13 65.00 3.10 
16.  
Ratan Paul 798188 .23 6.80 83.10 35.00 57.88 1.25 1.97 1.79 1.81 5.15 67.00 2.95 
17.  
Nitish Kumar 856546 .19 7.02 115.50 47.40 58.96 1.47 1.71 1.61 1.96 6.75 74.00 3.10 
18.  
Basant Yadav 854074 .14 6.90 87.70 37.90 56.78 1.18 1.49 1.83 1.76 5.49 87.00 2.80 
19.  
Piritosh 850648 .21 6.90 92.40 37.90 58.98 1.20 1.21 1.95 1.95 5.49 80.00 2.70 
20.  
Pritilata 859942 .17 7.16 65.90 24.60 62.67 1.25 1.31 1.91 2.03 3.44 81.00 3.00 
21.  















Perimeter INDEXTAS INDEXTAD 
1.  
Idrish 839314 2.60 6.70 9.30 1.45 1.64 
2.  
Bikram 854084 2.80 8.70 10.90 1.30 1.46 
3.  
Pravas 846462 2.70 8.00 .50 1.62 1.92 
4.  
Damodaran 412671 2.60 8.00 10.40 1.42 1.70 
5.  
shyamal 128811 2.40 6.20 8.90 1.38 1.53 
6.  
Vijayalakshmi 847954 2.35 7.00 8.80 1.79 2.00 
7.  
Asha singh 192234 2.70 7.30 9.70 1.40 1.64 
8.  
Duli Rani 856200 2.15 5.30 8.30 1.46 1.81 
9.  
Alice 460595 2.60 7.20 9.90 1.48 1.68 
10.  
Achama 038065 2.70 6.40 9.20 1.52 1.69 
11.  
Kamalakant 856699 2.60 7.10 10.00 1.61 1.87 
12.  
Gangammal 563848 2.70 6.80 9.10 1.24 1.47 
13.  
Takheyalyo 858833 2.70 7.10 9.60 1.79 2.01 
14.  
Ruckmani 849764 2.40 5.90 8.90 1.45 1.64 
15.  
Rajaul 794209 2.80 8.40 9.60 1.44 1.61 
16.  
Ratan Paul 798188 2.75 8.10 10.10 1.39 1.54 
17.  
Nitish Kumar 856546 2.80 8.70 10.20 1.29 1.60 
18.  
Basant Yadav 854074 2.65 7.42 9.60 1.36 1.52 
19.  
Piritosh 850648 2.40 6.50 8.80 1.14 1.28 
20.  
Pritilata 859942 2.60 6.30 9.20 1.46 1.64 
21.  









PROFORMA:   DATA ABSTRACTION FORM 
 
Date of Enrolment:                                                                                                            Enrolment No: 
NAME:    AGE:                         SEX:     1. Male / 2. Female      
 ID NO:                                             DOB: 
ADDRESS: 
PHONE: 1.                                                                                            2. 
Indication for Transthoracic ECHO / Clinical diagnosis: 
Height:                                                 Weight:                                                             BSA: 
1. Sinus rhythm /   2. Atrial Fibrillation 
NYHA functional class               1. I                              2. II                              3. III                         4. 1V 
Tricuspid Valve & Annulus Parameters 
End-systolic TA diameter  Vena Contracta  
End-diastolic TA diameter  Peak TR Velocity  
Tricuspid Annulus Contraction%  TR jet area  
TAPSE  EROA  
TV Tethering height  TR Severity  
TV Tethering area    
 
Right Ventricular parameters 
End-diastolic area  Systolic RV Pressure  
End-systolic area  Sphericity index  
Fractional area change  End-systolic EI  
RV Mid dimension  End-diastolic EI  
RV Long axis dimension  IVA=Peak isovolumic 
velocity/time to peak velocity 
 
RV Basal dimension  RV Tei index  
EI- eccentricity index 
Pulmonary Valve Parameters 
Estimated Systolic PA Pressure    
IVC & Hepatic Veins 
IVC Dimension  IVC Collapse  
Systolic flow reversal hepatic veins    
 
Right Atrial Parameters 
RA major dimension  Right atrial endsystolic area  
RA minor dimension    
 
Left Ventricular parameters 
LV EDV  LV Long axis dimension  
LVESV  LV Spherical Index  
LVEF    
 
Clinical Parameters 
Heart rate  NYHA Class  
Systolic BP  V Waves in JVP  
Diastolic BP  Typical Systolic murmur  
Diuretics  Edema  
Beta-blockers  Ascites  
ACEI  Pulsatile liver  
ARB  Sea-saw chest Movement  
CCB  Digoxin  
  
Three dimensional echocardiography parameters 
Tricuspid annulus area  Anterior angle  
Tricuspid annulus perimeter  Posterior Angle  
Anteroposterior annulus dimension  Septal angle  








INFORMED CONSENT FORM 
CONSENT AND SIGNATURE 
Please read the statements below, think about your choice, and sign if and when you are ready to 
agree, or take this form home and discuss it with anyone you wish to and then return it to us later 
if you wish to participate in this research:  
The primary investigator has fully explained to me the nature and purpose of this research 
project in a way that I have understood. He has responded to all of my questions and concerns in 
a satisfactory and respectful way.  
I have been offered opportunities to consult with an independent person, whom I trust, including 
a counselor or a physician, prior to my making my decision and has given me adequate time to 
decide.  
I hereby give my voluntary consent to participate in the research project entitled Functional TR: 
Mechanisms and determinants of severity. 
__________________________________Date:__________ __________________________  
Signature of Volunteer      Name  
 
 
__________________________________Date:__________ __________________________  
Signature of Person Obtaining Consent     Name  
  
PROJECT INFORMATION 
• The participation in this study is entirely voluntary.   
• There are no foreseeable physical risks for you in participating in this research project.  
• Study does not involve any invasive procedures, 
• This study is needed for research to learn more about the disorder in the hope of 
discovering new innovations of treatment.  
• Although you may not benefit directly from the study, there is potential benefit to other 
patients in future.  
• Your research and hospital records are confidential.  The records of your involvement 
with this research project will be kept confidential.  All records will be kept in a private 
database that can only be accessed by primary investigator.  Any report that the 
researchers publish will not include any information that will make it possible for readers 
to identify you.  
• The study will not affect the treatment being provided. There will be no additional 
charges for this study.  
• You will not receive any cash or payment with goods or services for participation in this 





 Glossary for Master data chart 
 
Key 
• Sex: 1-Male 2- Female 
• For V, murmur, edema, ascites, pulsatile liver, see saw chest, digoxin, beta blockers, 
ACEI, ARB, CCB, diuretics: 0- Absent 1- Present 
• Dx: 1. Rheumatic heart disease. 2. Dilated Cardiomyopathy 3. Ischemic Cardiomyopathy        
4. Primary pulmonary hypertension 5. COPD   6. Non rheumatic left valve disease 7. 
Cor pulmonale. 8. Porto-pulmonary hypertension 9. Hypertrophic cardiomyopathy 
 
Abbreviations 
ID    : Unique Identification No of the patient. 
ACEI   :  Angiotensin converting enzyme inhibitor 
ARB    :  Angiotensinogen receptor blocker 
Antero-posterior :  Anteroposterior tricuspid annulus dimension 
BSA   :  Body surface area 
CCB   :  Calcium channel blocker 
Dx   :  Diagnosis 
ESSI   :  Right Ventricular spherical index 
EDEI   :  Right ventricular end diastolic eccentricity index 
ESEI   :  Right ventricular end systolic eccentricity index  
EROA   :  Effective regurgitant orifice area 
IVC   :  Inferior Vena Cava dimension 
INDEX TAS  :  Indexed Tricuspid annulus end systolic dimension 
INDEX TAD  :  Tricuspid annulus end diastolic dimension 
LVEDV  :  Left ventricular end diastolic volume 
LVESV  :  Left ventricular end systolic volume 
LVEF   :  Left ventricular ejection fraction 
LV long  :  Left ventricular long axis dimension  
LVSI   : Left ventricular spherical index 
PASP   :  Pulmonary artery systolic pressure 
RAP   :  Estimated right atrial pressure 
RV Mid  :  Right ventricular mid dimension 
RV basal  :  Right ventricular basal dimension 
RV long  :  Right ventricular long axis dimension 
RVEDA  :  Right ventricular end diastolic area 
RVESA  :  Right ventricular end systolic area 
RVFAC  :  Right ventricular fractional area change 
IVA   :  Isovolumic acceleration 
Septolateral  :  Septal-lateral tricuspid annulus dimension 
TA   :  Tricuspid annulus 
TA area  :  Tricuspid annulus area 
TA Perimeter  : Tricuspid annulus perimeter 
TASYS  :  Tricuspid annulus end systolic dimension 
TADIAS  :  Tricuspid annulus end diastolic dimension 
TAC   :  Tricuspid annulus contraction 
TAPSE  : Tricuspid annulus plane systolic excursion 
TETH.A  :  Tethering area 
TETH. H  :  Tethering height 
V   : V waves in JVP 
VC    : Vena Contracta 
Glossary and List of Abbreviations 
ACC    : American College of Cardiology 
AF    : Atrial Fibrillation 
AHA    : American Heart Association 
ANOVA: Analysis Of Variance 
AVN      :   Atrioventricular node 
ASE       : American Society of Echocardiography 
CS    : Coronary sinus ostium 
DCMY   : Dilated Cardiomyopathy 
EI    : Eccentricity index 
ESC    : European Society of Cardiology 
FO    : Foramen ovale 
IVA    : Isovolumic Acceleration 
IVC    : Inferior Vena Cava 
LA    : Left Atrial 
LV    : Left Ventricle 
MPI    : Myocardial performance Index 
MR    : Mitral regurgitation 
NYHA    : New York Heart Association 
PISA    : Proximal Isovelocity Surface Area 
PASP     : Pulmonary Artery Systolic Pressure 
RA    : Right atrium 
RV    : Right Ventricle 
RVSP    : Right Ventricular Systolic Pressure  
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